| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | GABRB1 GABRB2 GABRB3 GABRP SLC26A4 GABRQ CCT8L2 GLRA2 GLRB LRRC8D SLC4A10 LRRC8A | 4.40e-07 | 151 | 249 | 12 | GO:0008509 |
| GeneOntologyMolecularFunction | monoatomic anion channel activity | GABRB1 GABRB2 GABRB3 GABRP GABRQ CCT8L2 GLRA2 GLRB LRRC8D LRRC8A | 6.48e-07 | 103 | 249 | 10 | GO:0005253 |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | GABRB1 GABRB2 GABRB3 GABRP ABCC3 SLC26A4 GABRQ GLRA2 GLRB ABCC2 SLC17A1 SLC4A10 | 1.66e-06 | 171 | 249 | 12 | GO:0015103 |
| GeneOntologyMolecularFunction | GABA-gated chloride ion channel activity | 2.17e-06 | 18 | 249 | 5 | GO:0022851 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic anion channel activity | 2.73e-06 | 50 | 249 | 7 | GO:0099095 | |
| GeneOntologyMolecularFunction | GABA-A receptor activity | 2.92e-06 | 19 | 249 | 5 | GO:0004890 | |
| GeneOntologyMolecularFunction | GABA receptor activity | 6.41e-06 | 22 | 249 | 5 | GO:0016917 | |
| GeneOntologyMolecularFunction | transmitter-gated channel activity | 1.62e-05 | 65 | 249 | 7 | GO:0022835 | |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity | 1.62e-05 | 65 | 249 | 7 | GO:0022824 | |
| GeneOntologyMolecularFunction | L-lactate dehydrogenase activity | 1.88e-05 | 5 | 249 | 3 | GO:0004459 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | GABRB1 GABRB2 GABRB3 GABRP SLC26A4 TRPC6 TRPM2 GABRQ RYR1 RYR3 CCT8L2 SLC8B1 GLRA2 GLRB SLC31A1 CALHM6 LASP1 LRRC8D PIEZO2 ATP2C1 SLC10A1 SLC17A1 KCNK10 SLC4A10 LRRC8A | 2.12e-05 | 793 | 249 | 25 | GO:0015075 |
| GeneOntologyMolecularFunction | chloride transmembrane transporter activity | 2.75e-05 | 125 | 249 | 9 | GO:0015108 | |
| GeneOntologyMolecularFunction | transporter activity | GABRB1 GABRB2 GABRB3 GABRP ABCC3 SLC26A4 TRPC6 TRPM2 GABRQ PITPNC1 RYR1 RYR3 ABCB4 CCT8L2 SLC8B1 GLRA2 GLRB HPX ABCC2 SLC31A1 ATG2B NPC2 APOB CALHM6 LASP1 LRRC8D PIEZO2 ATP2C1 SLC10A1 SLC17A1 KCNK10 SLC4A10 LRRC8A SLC33A1 | 2.86e-05 | 1289 | 249 | 34 | GO:0005215 |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | GABRB1 GABRB2 GABRB3 GABRP TRPM2 GABRQ RYR1 RYR3 CCT8L2 GLRA2 GLRB | 3.21e-05 | 193 | 249 | 11 | GO:0015276 |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity | 3.62e-05 | 100 | 249 | 8 | GO:0030594 | |
| GeneOntologyMolecularFunction | lactate dehydrogenase activity | 3.73e-05 | 6 | 249 | 3 | GO:0004457 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | GABRB1 GABRB2 GABRB3 GABRP TRPM2 GABRQ RYR1 RYR3 CCT8L2 GLRA2 GLRB | 3.87e-05 | 197 | 249 | 11 | GO:0022834 |
| GeneOntologyMolecularFunction | extracellular ligand-gated monoatomic ion channel activity | 4.93e-05 | 77 | 249 | 7 | GO:0005230 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | GABRB1 GABRB2 GABRB3 GABRP TRPC6 TRPM2 GABRQ RYR1 RYR3 CCT8L2 GLRA2 GLRB CALHM6 LRRC8D PIEZO2 KCNK10 LRRC8A | 6.87e-05 | 459 | 249 | 17 | GO:0005216 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on glycosyl bonds | 8.32e-05 | 144 | 249 | 9 | GO:0016798 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | ABCC3 ERCC6 MYO7A KIF1B MYO5C ABCB4 CCT8L2 ABCC2 DNA2 DHX29 DNAH9 KIF13B DDX17 DNAH1 ATP2C1 SLFN13 SMARCA2 SMARCA4 MYO15A DNAH11 | 9.39e-05 | 614 | 249 | 20 | GO:0140657 |
| GeneOntologyMolecularFunction | chloride channel activity | 1.00e-04 | 86 | 249 | 7 | GO:0005254 | |
| GeneOntologyMolecularFunction | inhibitory extracellular ligand-gated monoatomic ion channel activity | 1.02e-04 | 8 | 249 | 3 | GO:0005237 | |
| GeneOntologyMolecularFunction | interleukin-1 receptor activity | 1.02e-04 | 8 | 249 | 3 | GO:0004908 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 1.17e-04 | 118 | 249 | 8 | GO:0003774 | |
| GeneOntologyMolecularFunction | Rho-dependent protein serine/threonine kinase activity | 1.55e-04 | 2 | 249 | 2 | GO:0072518 | |
| GeneOntologyMolecularFunction | RNA polymerase binding | 1.58e-04 | 65 | 249 | 6 | GO:0070063 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | GABRB1 GABRB2 GABRB3 GABRP ABCC3 SLC26A4 TRPC6 TRPM2 GABRQ RYR1 RYR3 ABCB4 CCT8L2 SLC8B1 GLRA2 GLRB HPX ABCC2 SLC31A1 CALHM6 LASP1 LRRC8D PIEZO2 ATP2C1 SLC10A1 SLC17A1 KCNK10 SLC4A10 LRRC8A SLC33A1 | 1.68e-04 | 1180 | 249 | 30 | GO:0022857 |
| GeneOntologyMolecularFunction | protein kinase activity | LRRK2 CDKL3 SRPK2 MAP3K5 TXK NME2 ROCK2 CDC42BPA BAZ1B ZAP70 SCYL2 GUCY2C PRKACG ROCK1 PRKCE ATM MAPK11 FYN EPHB1 | 2.02e-04 | 600 | 249 | 19 | GO:0004672 |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | GABRB1 GABRB2 GABRB3 GABRP ABCC3 SLC26A4 TRPC6 TRPM2 GABRQ RYR1 RYR3 CCT8L2 SLC8B1 GLRA2 GLRB ABCC2 SLC31A1 ATP2C1 SLC10A1 SLC17A1 KCNK10 SLC4A10 | 2.20e-04 | 758 | 249 | 22 | GO:0015318 |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | LRRK2 CDKL3 SRPK2 PIGG MAP3K5 TXK PARP1 SHPK DGUOK NME2 ROCK2 CDC42BPA POLR2B GNPTAB BAZ1B ZAP70 SCYL2 GUCY2C PRKACG ROCK1 PRKCE ATM MAPK11 FYN EPHB1 | 3.01e-04 | 938 | 249 | 25 | GO:0016772 |
| GeneOntologyMolecularFunction | gated channel activity | GABRB1 GABRB2 GABRB3 GABRP TRPM2 GABRQ RYR1 RYR3 CCT8L2 GLRA2 GLRB PIEZO2 KCNK10 | 3.07e-04 | 334 | 249 | 13 | GO:0022836 |
| GeneOntologyMolecularFunction | channel activity | GABRB1 GABRB2 GABRB3 GABRP TRPC6 TRPM2 GABRQ RYR1 RYR3 CCT8L2 GLRA2 GLRB CALHM6 LRRC8D PIEZO2 KCNK10 LRRC8A | 3.38e-04 | 525 | 249 | 17 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | GABRB1 GABRB2 GABRB3 GABRP TRPC6 TRPM2 GABRQ RYR1 RYR3 CCT8L2 GLRA2 GLRB CALHM6 LRRC8D PIEZO2 KCNK10 LRRC8A | 3.45e-04 | 526 | 249 | 17 | GO:0022803 |
| GeneOntologyMolecularFunction | postsynaptic neurotransmitter receptor activity | 3.47e-04 | 75 | 249 | 6 | GO:0098960 | |
| GeneOntologyMolecularFunction | NAD+ nucleosidase activity | 3.88e-04 | 12 | 249 | 3 | GO:0003953 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | LRRK2 CDKL3 SRPK2 MAP3K5 TXK SHPK NME2 ROCK2 CDC42BPA BAZ1B ZAP70 SCYL2 GUCY2C PRKACG ROCK1 PRKCE ATM MAPK11 FYN EPHB1 | 6.08e-04 | 709 | 249 | 20 | GO:0016773 |
| GeneOntologyMolecularFunction | kinase activity | LRRK2 CDKL3 SRPK2 MAP3K5 TXK SHPK DGUOK NME2 ROCK2 CDC42BPA BAZ1B ZAP70 SCYL2 GUCY2C PRKACG ROCK1 PRKCE ATM MAPK11 FYN EPHB1 | 6.22e-04 | 764 | 249 | 21 | GO:0016301 |
| GeneOntologyMolecularFunction | transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potential | 7.15e-04 | 57 | 249 | 5 | GO:1904315 | |
| GeneOntologyMolecularFunction | neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential | 9.05e-04 | 60 | 249 | 5 | GO:0099529 | |
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 9.14e-04 | 4 | 249 | 2 | GO:0005219 | |
| GeneOntologyMolecularFunction | NAD+ nucleotidase, cyclic ADP-ribose generating | 9.51e-04 | 16 | 249 | 3 | GO:0061809 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ABCC3 ERCC6 KIF1B ABCB4 ABCC2 DNA2 DHX29 DNAH9 KIF13B DDX17 ATP2C1 SLFN13 SMARCA4 DNAH11 | 1.35e-03 | 441 | 249 | 14 | GO:0016887 |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 1.36e-03 | 18 | 249 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 1.36e-03 | 18 | 249 | 3 | GO:0015278 | |
| GeneOntologyMolecularFunction | basal RNA polymerase II transcription machinery binding | 1.39e-03 | 66 | 249 | 5 | GO:0001099 | |
| GeneOntologyMolecularFunction | basal transcription machinery binding | 1.39e-03 | 66 | 249 | 5 | GO:0001098 | |
| GeneOntologyMolecularFunction | long-chain fatty acyl-CoA binding | 1.51e-03 | 5 | 249 | 2 | GO:0036042 | |
| GeneOntologyMolecularFunction | histone H2AX kinase activity | 1.51e-03 | 5 | 249 | 2 | GO:0141003 | |
| GeneOntologyMolecularFunction | testosterone 6-beta-hydroxylase activity | 1.51e-03 | 5 | 249 | 2 | GO:0050649 | |
| GeneOntologyMolecularFunction | hydrolase activity, hydrolyzing N-glycosyl compounds | 1.66e-03 | 41 | 249 | 4 | GO:0016799 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 1.81e-03 | 70 | 249 | 5 | GO:0003777 | |
| GeneOntologyMolecularFunction | DNA endonuclease activity | 2.17e-03 | 44 | 249 | 4 | GO:0004520 | |
| GeneOntologyMolecularFunction | protein-cysteine S-myristoyltransferase activity | 2.25e-03 | 6 | 249 | 2 | GO:0019705 | |
| GeneOntologyMolecularFunction | calcium-induced calcium release activity | 2.25e-03 | 6 | 249 | 2 | GO:0048763 | |
| GeneOntologyMolecularFunction | extracellularly glycine-gated ion channel activity | 2.25e-03 | 6 | 249 | 2 | GO:0016933 | |
| GeneOntologyMolecularFunction | extracellularly glycine-gated chloride channel activity | 2.25e-03 | 6 | 249 | 2 | GO:0016934 | |
| GeneOntologyMolecularFunction | histone modifying activity | 2.40e-03 | 229 | 249 | 9 | GO:0140993 | |
| GeneOntologyMolecularFunction | tau-protein kinase activity | 2.48e-03 | 22 | 249 | 3 | GO:0050321 | |
| GeneOntologyMolecularFunction | intramolecular oxidoreductase activity, transposing S-S bonds | 2.48e-03 | 22 | 249 | 3 | GO:0016864 | |
| GeneOntologyMolecularFunction | protein disulfide isomerase activity | 2.48e-03 | 22 | 249 | 3 | GO:0003756 | |
| GeneOntologyMolecularFunction | non-membrane spanning protein tyrosine kinase activity | 2.55e-03 | 46 | 249 | 4 | GO:0004715 | |
| GeneOntologyMolecularFunction | protein-cysteine S-stearoyltransferase activity | 3.12e-03 | 7 | 249 | 2 | GO:0140439 | |
| GeneOntologyBiologicalProcess | monoatomic anion transmembrane transport | GABRB1 GABRB2 GABRB3 GABRP ABCC3 SLC26A4 GABRQ CCT8L2 GLRA2 GLRB ABCC2 LRRC8D SLC4A10 LRRC8A | 4.48e-09 | 153 | 246 | 14 | GO:0098656 |
| GeneOntologyBiologicalProcess | monoatomic anion transport | GABRB1 GABRB2 GABRB3 GABRP ABCC3 SLC26A4 GABRQ CCT8L2 GLRA2 GLRB ABCC2 LRRC8D SLC17A1 SLC4A10 LRRC8A | 5.68e-09 | 183 | 246 | 15 | GO:0006820 |
| GeneOntologyBiologicalProcess | chloride transport | GABRB1 GABRB2 GABRB3 GABRP SLC26A4 GABRQ GLRA2 GLRB SLC4A10 LRRC8A | 3.21e-06 | 128 | 246 | 10 | GO:0006821 |
| GeneOntologyBiologicalProcess | inorganic anion transmembrane transport | GABRB1 GABRB2 GABRB3 GABRP SLC26A4 GABRQ GLRA2 GLRB SLC17A1 LRRC8A | 4.85e-06 | 134 | 246 | 10 | GO:0098661 |
| GeneOntologyBiologicalProcess | chloride transmembrane transport | 7.97e-06 | 112 | 246 | 9 | GO:1902476 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | GABRB1 GABRB2 GABRB3 GABRP EPO ABCC3 SLC26A4 TRPC6 TRPM2 GABRQ RYR1 RYR3 SLC35G1 CCT8L2 SLC8B1 GLRA2 GLRB ABCC2 SLC31A1 CASQ2 CALHM6 LASP1 LRRC8D PIEZO2 ATP2C1 SLC17A1 KCNK10 SLC4A10 LRRC8A PRKCE FYN | 1.04e-05 | 1115 | 246 | 31 | GO:0034220 |
| GeneOntologyBiologicalProcess | inorganic anion transport | GABRB1 GABRB2 GABRB3 GABRP SLC26A4 GABRQ GLRA2 GLRB SLC17A1 SLC4A10 LRRC8A | 1.11e-05 | 180 | 246 | 11 | GO:0015698 |
| GeneOntologyBiologicalProcess | base-excision repair | 1.70e-05 | 46 | 246 | 6 | GO:0006284 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | GABRB1 GABRB2 GABRB3 GABRP EPO ABCC3 SLC26A4 TRPC6 TRPM2 GABRQ HEPH RYR1 RYR3 SLC35G1 CCT8L2 SLC8B1 GLRA2 GLRB HPX ABCC2 SLC31A1 CASQ2 SPG11 CALHM6 LASP1 LRRC8D PIEZO2 ATP2C1 SLC10A1 SLC17A1 KCNK10 SLC4A10 LRRC8A PRKCE FYN | 1.75e-05 | 1374 | 246 | 35 | GO:0006811 |
| GeneOntologyBiologicalProcess | cellular response to purine-containing compound | 1.80e-05 | 14 | 246 | 4 | GO:0071415 | |
| GeneOntologyBiologicalProcess | cellular response to histamine | 5.66e-05 | 7 | 246 | 3 | GO:0071420 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase I | 7.40e-05 | 37 | 246 | 5 | GO:0045943 | |
| GeneOntologyCellularComponent | GABA-A receptor complex | 2.38e-06 | 19 | 250 | 5 | GO:1902711 | |
| GeneOntologyCellularComponent | GABA receptor complex | 4.09e-06 | 21 | 250 | 5 | GO:1902710 | |
| GeneOntologyCellularComponent | chloride channel complex | 5.11e-06 | 57 | 250 | 7 | GO:0034707 | |
| GeneOntologyCellularComponent | junctional membrane complex | 1.35e-04 | 9 | 250 | 3 | GO:0030314 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | GABRB1 GABRB2 GABRB3 GABRP TRPC6 GABRQ RYR1 RYR3 GLRA2 GLRB CASQ2 LRRC8D KCNK10 LRRC8A | 1.97e-04 | 378 | 250 | 14 | GO:0034702 |
| HumanPheno | Cerebral cortical atrophy | PUS3 ERCC5 ERCC6 FRMPD4 MYO7A LRRK2 CASZ1 SACS DGUOK PGAP1 B3GLCT GNPTAB BAZ1B SPG11 EPG5 SCYL2 KMT2D CTDP1 PARN SORL1 | 2.29e-06 | 346 | 92 | 20 | HP:0002120 |
| HumanPheno | Atrophy/Degeneration affecting the cerebrum | GABRB2 PUS3 ERCC5 ERCC6 FRMPD4 MYO7A LRRK2 PIGG CASZ1 SACS SHPK ALG14 DGUOK PGAP1 MOCS2 B3GLCT SLC31A1 GNPTAB BAZ1B SPG11 HUWE1 EPG5 SCYL2 KMT2D CTDP1 MTR PARN SLC33A1 SORL1 | 1.91e-05 | 733 | 92 | 29 | HP:0007369 |
| HumanPheno | Cerebral atrophy | GABRB2 PUS3 ERCC5 ERCC6 FRMPD4 MYO7A LRRK2 PIGG CASZ1 SACS ALG14 DGUOK PGAP1 MOCS2 B3GLCT SLC31A1 GNPTAB BAZ1B SPG11 HUWE1 EPG5 SCYL2 KMT2D CTDP1 MTR PARN SLC33A1 SORL1 | 3.70e-05 | 718 | 92 | 28 | HP:0002059 |
| Domain | GABAA/Glycine_rcpt | 4.01e-07 | 23 | 245 | 6 | IPR006028 | |
| Domain | Neurotransmitter_ion_chnl_CS | 1.82e-06 | 45 | 245 | 7 | IPR018000 | |
| Domain | Neur_chan_memb | 2.12e-06 | 46 | 245 | 7 | PF02932 | |
| Domain | GABAAb_rcpt | 2.23e-06 | 3 | 245 | 3 | IPR002289 | |
| Domain | Neur_chan_LBD | 2.47e-06 | 47 | 245 | 7 | PF02931 | |
| Domain | NEUROTR_ION_CHANNEL | 2.47e-06 | 47 | 245 | 7 | PS00236 | |
| Domain | Neur_channel | 2.47e-06 | 47 | 245 | 7 | IPR006201 | |
| Domain | Neur_chan_lig-bd | 2.47e-06 | 47 | 245 | 7 | IPR006202 | |
| Domain | Neurotrans-gated_channel_TM | 2.47e-06 | 47 | 245 | 7 | IPR006029 | |
| Domain | - | 2.47e-06 | 47 | 245 | 7 | 2.70.170.10 | |
| Domain | ARM-type_fold | NBEAL1 LRRK2 RYR3 DOCK1 IPO5 UBR4 RANBP6 APOB FRYL HUWE1 RALGAPA2 SCYL2 FMNL3 INTS4 ATM BZW1 XPOT | 2.63e-06 | 339 | 245 | 17 | IPR016024 |
| Domain | L-lactate_DH_AS | 2.19e-05 | 5 | 245 | 3 | IPR018177 | |
| Domain | L_LDH | 2.19e-05 | 5 | 245 | 3 | PS00064 | |
| Domain | L-lactate_DH | 2.19e-05 | 5 | 245 | 3 | IPR011304 | |
| Domain | Lactate/malate_DH_N | 1.19e-04 | 8 | 245 | 3 | IPR001236 | |
| Domain | L-lactate/malate_DH | 1.19e-04 | 8 | 245 | 3 | IPR001557 | |
| Domain | Ldh_1_N | 1.19e-04 | 8 | 245 | 3 | PF00056 | |
| Domain | QLQ | 1.71e-04 | 2 | 245 | 2 | SM00951 | |
| Domain | Rho_Binding | 1.71e-04 | 2 | 245 | 2 | PF08912 | |
| Domain | SnAC | 1.71e-04 | 2 | 245 | 2 | SM01314 | |
| Domain | SnAC | 1.71e-04 | 2 | 245 | 2 | IPR029295 | |
| Domain | Gln-Leu-Gln_QLQ | 1.71e-04 | 2 | 245 | 2 | IPR014978 | |
| Domain | SnAC | 1.71e-04 | 2 | 245 | 2 | PF14619 | |
| Domain | QLQ | 1.71e-04 | 2 | 245 | 2 | PS51666 | |
| Domain | Rho-bd_dom | 1.71e-04 | 2 | 245 | 2 | IPR015008 | |
| Domain | ROCK1/ROCK2 | 1.71e-04 | 2 | 245 | 2 | IPR020684 | |
| Domain | QLQ | 1.71e-04 | 2 | 245 | 2 | PF08880 | |
| Domain | - | 1.77e-04 | 9 | 245 | 3 | 3.90.110.10 | |
| Domain | Lactate/malate_DH_C | 1.77e-04 | 9 | 245 | 3 | IPR022383 | |
| Domain | Ldh_1_C | 1.77e-04 | 9 | 245 | 3 | PF02866 | |
| Domain | Lactate_DH/Glyco_Ohase_4_C | 1.77e-04 | 9 | 245 | 3 | IPR015955 | |
| Domain | IL-1_rcpt_fam | 3.40e-04 | 11 | 245 | 3 | IPR015621 | |
| Domain | Protein_kinase_ATP_BS | LRRK2 CDKL3 SRPK2 MAP3K5 TXK ROCK2 CDC42BPA ZAP70 PRKACG ROCK1 PRKCE MAPK11 FYN EPHB1 | 5.07e-04 | 379 | 245 | 14 | IPR017441 |
| Domain | RyR | 5.10e-04 | 3 | 245 | 2 | PF02026 | |
| Domain | RR_TM4-6 | 5.10e-04 | 3 | 245 | 2 | PF06459 | |
| Domain | Ryan_recept | 5.10e-04 | 3 | 245 | 2 | IPR013333 | |
| Domain | Ryanodine_rcpt | 5.10e-04 | 3 | 245 | 2 | IPR003032 | |
| Domain | Ryanrecept_TM4-6 | 5.10e-04 | 3 | 245 | 2 | IPR009460 | |
| Domain | PH_dom-like | AGAP5 FRMPD4 MYO7A NBEAL1 KIF1B TBC1D2B OSBP2 TECPR1 ROCK2 CDC42BPA FRMPD1 MTMR6 ROCK1 AGAP9 PSD4 | 5.31e-04 | 426 | 245 | 15 | IPR011993 |
| Domain | ConA-like_dom | NBEAL1 RYR1 RYR3 NELL2 COL21A1 FAT4 COL5A3 ASH2L TRIM16 EGFLAM | 6.53e-04 | 219 | 245 | 10 | IPR013320 |
| Domain | ATPase_dyneun-rel_AAA | 7.29e-04 | 14 | 245 | 3 | IPR011704 | |
| Domain | MT | 7.29e-04 | 14 | 245 | 3 | PF12777 | |
| Domain | AAA_8 | 7.29e-04 | 14 | 245 | 3 | PF12780 | |
| Domain | AAA_5 | 7.29e-04 | 14 | 245 | 3 | PF07728 | |
| Domain | Dynein_heavy_chain_D4_dom | 7.29e-04 | 14 | 245 | 3 | IPR024317 | |
| Domain | Dynein_HC_stalk | 7.29e-04 | 14 | 245 | 3 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 7.29e-04 | 14 | 245 | 3 | IPR013602 | |
| Domain | DHC_N2 | 7.29e-04 | 14 | 245 | 3 | PF08393 | |
| Domain | Prot_kinase_dom | LRRK2 CDKL3 SRPK2 MAP3K5 TXK ROCK2 CDC42BPA ZAP70 SCYL2 GUCY2C PRKACG ROCK1 PRKCE MAPK11 FYN EPHB1 | 7.69e-04 | 489 | 245 | 16 | IPR000719 |
| Domain | P-loop_NTPase | ABCC3 ERCC6 MYO7A KIF1B LRRK2 MYO5C ABCB4 TRANK1 DGUOK ABCC2 DNA2 DHX29 DNAH9 KIF13B DDX17 DNAH1 GNA14 SLFN13 SMARCA2 SMARCA4 AGAP9 MYO15A DNAH11 | 8.18e-04 | 848 | 245 | 23 | IPR027417 |
| Domain | AGC-kinase_C | 8.26e-04 | 56 | 245 | 5 | IPR000961 | |
| Domain | S_TK_X | 8.26e-04 | 56 | 245 | 5 | SM00133 | |
| Domain | AGC_KINASE_CTER | 8.26e-04 | 56 | 245 | 5 | PS51285 | |
| Domain | PROTEIN_KINASE_DOM | LRRK2 CDKL3 SRPK2 MAP3K5 TXK ROCK2 CDC42BPA ZAP70 SCYL2 GUCY2C PRKACG ROCK1 PRKCE MAPK11 FYN EPHB1 | 8.38e-04 | 493 | 245 | 16 | PS50011 |
| Domain | Kinase-like_dom | LRRK2 CDKL3 SRPK2 MAP3K5 TXK ROCK2 CDC42BPA ZAP70 SCYL2 GUCY2C PRKACG ROCK1 PRKCE ATM MAPK11 FYN EPHB1 | 8.46e-04 | 542 | 245 | 17 | IPR011009 |
| Domain | DHC_fam | 9.03e-04 | 15 | 245 | 3 | IPR026983 | |
| Domain | Dynein_heavy | 9.03e-04 | 15 | 245 | 3 | PF03028 | |
| Domain | Dynein_heavy_dom | 9.03e-04 | 15 | 245 | 3 | IPR004273 | |
| Domain | Laminin_G | 9.70e-04 | 58 | 245 | 5 | IPR001791 | |
| Domain | - | 1.01e-03 | 4 | 245 | 2 | 1.10.10.440 | |
| Domain | HSA | 1.01e-03 | 4 | 245 | 2 | SM00573 | |
| Domain | Multidrug-R_assoc | 1.01e-03 | 4 | 245 | 2 | IPR005292 | |
| Domain | Calsequestrin | 1.01e-03 | 4 | 245 | 2 | IPR001393 | |
| Domain | Peroxin/Ferlin | 1.01e-03 | 4 | 245 | 2 | IPR006614 | |
| Domain | Kinesin-like_KIF1-typ | 1.01e-03 | 4 | 245 | 2 | IPR022140 | |
| Domain | KIF1B | 1.01e-03 | 4 | 245 | 2 | PF12423 | |
| Domain | HSA | 1.01e-03 | 4 | 245 | 2 | PS51204 | |
| Domain | DysFC | 1.01e-03 | 4 | 245 | 2 | SM00694 | |
| Domain | DysFN | 1.01e-03 | 4 | 245 | 2 | SM00693 | |
| Domain | HSA_dom | 1.01e-03 | 4 | 245 | 2 | IPR014012 | |
| Domain | HSA | 1.01e-03 | 4 | 245 | 2 | PF07529 | |
| Domain | - | 1.10e-03 | 35 | 245 | 4 | 3.20.20.80 | |
| Domain | Pkinase_C | 1.36e-03 | 37 | 245 | 4 | IPR017892 | |
| Domain | Glyco_hydro_catalytic_dom | 1.50e-03 | 38 | 245 | 4 | IPR013781 | |
| Domain | - | 1.57e-03 | 95 | 245 | 6 | 2.60.120.200 | |
| Domain | LRRC8_Pannexin-like | 1.67e-03 | 5 | 245 | 2 | IPR021040 | |
| Domain | Spc97_Spc98 | 1.67e-03 | 5 | 245 | 2 | PF04130 | |
| Domain | Cyt_P450_E_grp-II | 1.67e-03 | 5 | 245 | 2 | IPR002402 | |
| Domain | GCP | 1.67e-03 | 5 | 245 | 2 | IPR007259 | |
| Domain | Pannexin_like | 1.67e-03 | 5 | 245 | 2 | PF12534 | |
| Domain | Laminin_G_2 | 1.82e-03 | 40 | 245 | 4 | PF02210 | |
| Domain | VWC_out | 1.85e-03 | 19 | 245 | 3 | SM00215 | |
| Domain | - | ABCC3 ERCC6 MYO7A LRRK2 ABCB4 TRANK1 DGUOK ABCC2 DNA2 DHX29 DNAH9 DDX17 DNAH1 GNA14 SLFN13 SMARCA2 SMARCA4 AGAP9 MYO15A DNAH11 | 2.04e-03 | 746 | 245 | 20 | 3.40.50.300 |
| Domain | Pkinase_C | 2.19e-03 | 42 | 245 | 4 | PF00433 | |
| Domain | BRK | 2.48e-03 | 6 | 245 | 2 | SM00592 | |
| Domain | Cyt_P450_E_CYP3A | 2.48e-03 | 6 | 245 | 2 | IPR008072 | |
| Domain | Kinesin_assoc | 2.48e-03 | 6 | 245 | 2 | PF16183 | |
| Domain | FF_domain | 2.48e-03 | 6 | 245 | 2 | IPR002713 | |
| Domain | FF | 2.48e-03 | 6 | 245 | 2 | SM00441 | |
| Domain | Ryanodine_recept-rel | 2.48e-03 | 6 | 245 | 2 | IPR015925 | |
| Domain | Kinesin_assoc | 2.48e-03 | 6 | 245 | 2 | IPR032405 | |
| Domain | - | 2.48e-03 | 6 | 245 | 2 | 1.25.10.30 | |
| Domain | RIH_assoc-dom | 2.48e-03 | 6 | 245 | 2 | IPR013662 | |
| Domain | BRK_domain | 2.48e-03 | 6 | 245 | 2 | IPR006576 | |
| Domain | FF | 2.48e-03 | 6 | 245 | 2 | PS51676 | |
| Domain | Ins145_P3_rec | 2.48e-03 | 6 | 245 | 2 | PF08709 | |
| Domain | Kinesin-like | 2.48e-03 | 6 | 245 | 2 | IPR022164 | |
| Domain | FF | 2.48e-03 | 6 | 245 | 2 | PF01846 | |
| Domain | RIH_assoc | 2.48e-03 | 6 | 245 | 2 | PF08454 | |
| Domain | RIH_dom | 2.48e-03 | 6 | 245 | 2 | IPR000699 | |
| Pathway | WP_MBDNF_AND_PROBDNF_REGULATION_OF_GABA_NEUROTRANSMISSION | 1.17e-05 | 38 | 193 | 6 | M39854 | |
| Pathway | WP_GABA_RECEPTOR_SIGNALING | 5.81e-05 | 31 | 193 | 5 | M39369 | |
| Pathway | WP_DRUG_INDUCTION_OF_BILE_ACID_PATHWAY | 7.05e-05 | 17 | 193 | 4 | M39666 | |
| Pathway | KEGG_CYSTEINE_AND_METHIONINE_METABOLISM | 9.20e-05 | 34 | 193 | 5 | M10911 | |
| Pathway | BIOCARTA_NUCLEARRS_PATHWAY | 9.20e-05 | 34 | 193 | 5 | M16393 | |
| Pathway | WP_CHOLESTASIS | 1.12e-04 | 19 | 193 | 4 | M45520 | |
| Pathway | WP_FARNESOID_X_RECEPTOR_PATHWAY | 1.12e-04 | 19 | 193 | 4 | M39411 | |
| Pubmed | NOLC1 RPS3A HNF4A MYO5C SCAF4 MED24 TCERG1 MKI67 PPIL2 NME2 H1-10 CDC42BPA UBR4 ETV7 BAZ1B LASP1 ASH2L RING1 PCF11 PDIA4 MRPL17 KMT2D PPP6C MRPS23 SMARCA2 MTR SMARCA4 MRPS5 ASXL2 KDM1B XPOT SORL1 | 1.71e-08 | 1429 | 252 | 32 | 35140242 | |
| Pubmed | NOLC1 ERCC5 NEMP2 MED24 AREL1 WDR75 PTPRR PGAP1 DNA2 KIF13B POLR2B FRMPD1 BAZ1B APOB FRYL HUWE1 PPCS ASH2L PDIA4 MTMR6 PPP6C ROCK1 ASXL2 FUCA2 KDM1B SLC33A1 XPOT | 2.91e-08 | 1084 | 252 | 27 | 11544199 | |
| Pubmed | NOLC1 RPS3A SRPK2 DMXL1 SH3BP4 PARP1 WDR75 SACS DDHD2 DNA2 DHX29 H1-10 PDPR CDC42BPA DNAJC16 POLR2B UBR4 BAZ1B SPG11 AAR2 PCF11 PDIA4 MRPL17 NBAS PPP6C MRPS23 MTR MRPS5 TTC17 ATM SLC33A1 SNX1 | 4.29e-08 | 1487 | 252 | 32 | 33957083 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | ABCC3 MANBA PIGG DMXL1 NELL2 PTPN12 PGAP1 ROCK2 ATRN FAT4 B3GLCT DNAJC16 GNPTAB CRELD2 RANBP6 NPC2 LRRC8D PDIA4 MYOF USP5 LRRC8A TTC17 LY6K FUCA2 ATM SLC33A1 SNX1 SORL1 | 6.31e-08 | 1201 | 252 | 28 | 35696571 |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | ACOT7 RYR1 PARP1 IPO5 H1-10 DDX17 UBR4 COL5A3 DPP3 PPA1 HUWE1 LDHA EPG5 DNAH1 PDIA4 NBAS MYOF USP5 SMS BZW1 MYO15A XPOT | 1.30e-07 | 807 | 252 | 22 | 30575818 |
| Pubmed | 1.39e-07 | 81 | 252 | 8 | 22723691 | ||
| Pubmed | 1.52e-07 | 18 | 252 | 5 | 19078961 | ||
| Pubmed | 2.43e-07 | 87 | 252 | 8 | 12465718 | ||
| Pubmed | NOLC1 TDRD15 PUS3 RPS3A KIF1B LRRK2 DMXL1 SH3BP4 DNASE2B MKI67 FAT4 DDX17 CDC42BPA DNAJC16 APOB HUWE1 LDHA BTBD3 PCF11 SLFN13 SNX1 | 2.92e-07 | 777 | 252 | 21 | 35844135 | |
| Pubmed | SRPK2 PIGG PARP1 PTPN12 WDR75 MKI67 ROCK2 IPO5 ATRN DDX17 POLR2B UBR4 CRELD2 NPC2 APOB LDHA RING1 PDIA4 MYOF MTMR6 PREP MRPS23 PARN TTC17 BZW1 FYN SNX1 XPOT | 3.02e-07 | 1297 | 252 | 28 | 33545068 | |
| Pubmed | 3.55e-07 | 21 | 252 | 5 | 25708312 | ||
| Pubmed | NOLC1 RPS3A TTF1 WDR75 MKI67 IPO5 H1-10 UBR4 BAZ1B FRYL HUWE1 PDIA4 USP5 PREP SMARCA2 SMARCA4 PARN ATM XPOT | 3.64e-07 | 653 | 252 | 19 | 22586326 | |
| Pubmed | 3.76e-07 | 3 | 252 | 3 | 1282920 | ||
| Pubmed | GABAA receptor beta subunit mRNA expression in the human alcoholic brain. | 3.76e-07 | 3 | 252 | 3 | 15337300 | |
| Pubmed | GABAA receptor beta 1, beta 2, and beta 3 subunits: comparisons in DBA/2J and C57BL/6J mice. | 3.76e-07 | 3 | 252 | 3 | 7893750 | |
| Pubmed | Expression and distribution of GABAA receptor subtypes in human alcoholic cerebral cortex. | 3.76e-07 | 3 | 252 | 3 | 11085308 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | NOLC1 ERCC6 RPS3A ACOT7 PARP1 PTPN12 WDR75 TCERG1 MKI67 DHX29 H1-10 DDX17 POLR2B UBR4 BAZ1B LASP1 PPA1 HUWE1 LDHA WDR59 AAR2 RING1 USP5 PPP6C MRPS23 SMARCA2 SMARCA4 XPOT | 6.97e-07 | 1353 | 252 | 28 | 29467282 |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | ACOT7 PTPN12 PTPRR AGL DHX29 ROCK2 IPO5 DNAJC16 UBR4 RANBP6 HUWE1 AAR2 PDIA4 USP5 MTMR6 ATP2C1 PREP TTC17 SMS BZW1 MAPK11 XPOT SORL1 | 8.17e-07 | 974 | 252 | 23 | 28675297 |
| Pubmed | NOLC1 ERCC6 RPS3A SH3BP4 PTPN12 MKI67 DHX29 MOCS2 DOCK1 ROCK2 DDX17 HUWE1 USP5 CTDP1 PARN BZW1 | 9.89e-07 | 503 | 252 | 16 | 16964243 | |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | TTF1 MED24 QSOX1 ALG14 PDPR LMCD1 GPR37 RANBP6 SPG11 APOB PPA1 HUWE1 LRRC8D TRIM16 ZDHHC20 MYOF SLC4A10 LRRC8A INTS4 SMS ATM SLC33A1 SNX1 XPOT | 9.93e-07 | 1061 | 252 | 24 | 33845483 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | NOLC1 ERCC5 KIF1B SCAF4 MED24 QSOX1 MKI67 DHX29 ROCK2 H1-10 BAZ1B HUWE1 PCF11 TRIM16 MYOF KMT2D CTDP1 SMARCA2 SMARCA4 ATM | 1.13e-06 | 774 | 252 | 20 | 15302935 |
| Pubmed | AGAP5 ERCC6 FRMPD4 MYO7A LRRK2 TUBGCP5 QSOX1 PARP1 WDR75 FAT4 DDX17 IQCH ATG2B COL5A3 APOB TECTA | 1.28e-06 | 513 | 252 | 16 | 25798074 | |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | NOLC1 TUBGCP2 MED24 WDR75 FAM120C MKI67 KIF13B POLR2B UBR4 BAZ1B KMT2D PRKACG PARN | 1.46e-06 | 341 | 252 | 13 | 32971831 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | KIF1B TRPM2 NFASC SRPK2 TTF1 CASZ1 SH3BP4 SLC8B1 PTPRR FAM120C KLHL23 DOCK1 ATRN CDC42BPA SLC31A1 KAT6A FRMPD1 HECTD4 FRYL HUWE1 TECTA LRRC8D DNAH1 ATP2C1 FAM111A USP40 SMARCA2 PRKCE TTC17 | 1.47e-06 | 1489 | 252 | 29 | 28611215 |
| Pubmed | 1.50e-06 | 4 | 252 | 3 | 17344417 | ||
| Pubmed | 1.50e-06 | 4 | 252 | 3 | 19805516 | ||
| Pubmed | Heterogeneity of Hereditary Hearing Loss in Iran: a Comprehensive Review. | 1.50e-06 | 4 | 252 | 3 | 27743438 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | NOLC1 ERCC5 RPS3A SRPK2 PARP1 TCERG1 AGL PPIL2 MOCS2 ROCK2 IPO5 H1-10 DDX17 POLR2B UBR4 LASP1 PPA1 HUWE1 LDHA LRRC8D AAR2 USP5 MRPS23 SMARCA4 MRPS5 BZW1 SNX1 XPOT | 1.67e-06 | 1415 | 252 | 28 | 28515276 |
| Pubmed | NOLC1 TUBGCP2 SCAF4 MED24 PARP1 TCERG1 MKI67 PPIL2 NME2 DDX17 AASDH LASP1 DPP3 PPA1 LDHA PCF11 PDIA4 KMT2D SMARCA2 SMARCA4 SMS ASXL2 BZW1 XPOT | 1.95e-06 | 1103 | 252 | 24 | 34189442 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | MYO5C DOCK1 IPO5 DDX17 CDC42BPA FRYL NBAS MYOF SMARCA2 TTC17 | 2.46e-06 | 202 | 252 | 10 | 33005030 |
| Pubmed | 2.54e-06 | 14 | 252 | 4 | 8605874 | ||
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | NOLC1 RPS3A KIF1B ACOT7 PTPN12 AGL ROCK2 IPO5 H1-10 DDX17 POLR2B UBR4 LDHAL6B RANBP6 FRYL DPP3 HUWE1 LDHA PDIA4 TRIM16 USP5 PPP6C MTR ROCK1 SMS BZW1 SNX1 XPOT | 2.84e-06 | 1455 | 252 | 28 | 22863883 |
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | NOLC1 TUBGCP2 WDR75 UBR4 HUWE1 ASH2L AAR2 FMNL3 USP5 MTR ATM XPOT | 3.52e-06 | 313 | 252 | 12 | 38270169 |
| Pubmed | Protein kinase C-epsilon regulates local calcium signaling in airway smooth muscle cells. | 3.72e-06 | 5 | 252 | 3 | 19011160 | |
| Pubmed | 3.72e-06 | 5 | 252 | 3 | 34555357 | ||
| Pubmed | 3.72e-06 | 5 | 252 | 3 | 15198677 | ||
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | RPS3A ACOT7 AGL DHX29 LCMT1 KIF13B DDX17 PDPR POLR2B UBR4 BAZ1B LASP1 HUWE1 NBAS MRPS23 SMARCA2 SMARCA4 SMS | 4.55e-06 | 704 | 252 | 18 | 29955894 |
| Pubmed | NOLC1 RPS3A KIF1B ACOT7 SRPK2 SH3BP4 PARP1 MKI67 PPIL2 NME2 ROCK2 IPO5 H1-10 DDX17 CDC42BPA POLR2B LASP1 PPA1 HUWE1 DNAH1 RING1 MYOF PPP6C SMARCA2 FYN | 4.96e-06 | 1247 | 252 | 25 | 27684187 | |
| Pubmed | Generation and annotation of the DNA sequences of human chromosomes 2 and 4. | MGAT4D UBTFL6 TIGD1 IL18RAP NEMP2 SH3BP4 WDR75 PGAP1 USP40 SLC4A10 PRKCE IL1RL1 BZW1 PSD4 | 4.98e-06 | 442 | 252 | 14 | 15815621 |
| Pubmed | NOLC1 MED24 PARP1 TCERG1 MKI67 MBD4 IPO5 POLR2B UBR4 BAZ1B LASP1 PPA1 RING1 USP5 SMARCA2 SMARCA4 PARN SMS ATM BZW1 KDM1B MYO15A | 5.55e-06 | 1014 | 252 | 22 | 32416067 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | NOLC1 TUBGCP2 PARP1 FAM120C DOCK1 ROCK2 IPO5 DDX17 HUWE1 SCYL2 PCF11 GNA14 SMARCA2 SMARCA4 ATM BZW1 | 6.36e-06 | 582 | 252 | 16 | 20467437 |
| Pubmed | DMXL1 MKI67 DHX29 DDX17 POLR2B UBR4 BAZ1B ASH2L USP5 KDM7A BZW1 XPOT | 7.01e-06 | 335 | 252 | 12 | 15741177 | |
| Pubmed | The GABAA Receptor β Subunit Is Required for Inhibitory Transmission. | 7.40e-06 | 6 | 252 | 3 | 29706582 | |
| Pubmed | 7.40e-06 | 6 | 252 | 3 | 15753128 | ||
| Pubmed | Roles of Brahma and Brahma/SWI2-related gene 1 in hypoxic induction of the erythropoietin gene. | 7.40e-06 | 6 | 252 | 3 | 15347669 | |
| Pubmed | Evolution of GABA(A) receptor diversity in the human genome. | 7.40e-06 | 6 | 252 | 3 | 10023064 | |
| Pubmed | Alternative p38 activation pathway mediated by T cell receptor-proximal tyrosine kinases. | 7.40e-06 | 6 | 252 | 3 | 15735648 | |
| Pubmed | SRPK2 DMXL1 DNASE2B PPIL2 DDX17 CDC42BPA POLR2B KAT6A PPA1 MTMR6 ATP2C1 SMARCA2 SMARCA4 PRKCE KDM1B MAPK11 FYN DNAH11 | 7.45e-06 | 730 | 252 | 18 | 34857952 | |
| Pubmed | 7.94e-06 | 182 | 252 | 9 | 15102471 | ||
| Pubmed | NOLC1 AGAP5 TBC1D2B NFASC HEPH TRANK1 DNA2 PDPR CDC42BPA HECTD4 SPG11 FMNL3 LRRC8A KDM7A AGAP9 | 8.63e-06 | 529 | 252 | 15 | 14621295 | |
| Pubmed | The cell proliferation antigen Ki-67 organises heterochromatin. | TIGD1 SRPK2 TTF1 MED24 MKI67 IPO5 LDHA ASH2L MRPL17 FMNL3 KMT2D FAM111A SMARCA2 | 1.08e-05 | 410 | 252 | 13 | 26949251 |
| Pubmed | Resetting the epigenetic balance of Polycomb and COMPASS function at enhancers for cancer therapy. | 1.19e-05 | 20 | 252 | 4 | 29785026 | |
| Pubmed | MANBA HEPH IPO5 ATRN DDX17 POLR2B PPA1 HUWE1 LDHA SCYL2 PPP6C SMARCA4 TTC17 FUCA2 XPOT SORL1 | 1.21e-05 | 613 | 252 | 16 | 22268729 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | RPS3A ACOT7 SRPK2 SCAF4 PARP1 TCERG1 AGL NME2 IPO5 H1-10 DDX17 POLR2B UBR4 PPA1 HUWE1 LDHA ASH2L PDIA4 USP5 PPP6C PREP MRPS23 MRPS5 | 1.24e-05 | 1149 | 252 | 23 | 35446349 |
| Pubmed | 1.29e-05 | 7 | 252 | 3 | 31980388 | ||
| Pubmed | theta, a novel gamma-aminobutyric acid type A receptor subunit. | 1.29e-05 | 7 | 252 | 3 | 10449790 | |
| Pubmed | 1.29e-05 | 7 | 252 | 3 | 9047237 | ||
| Pubmed | 1.29e-05 | 7 | 252 | 3 | 29162624 | ||
| Pubmed | Lamina-specific alterations in cortical GABA(A) receptor subunit expression in schizophrenia. | 1.29e-05 | 7 | 252 | 3 | 20843900 | |
| Pubmed | 1.29e-05 | 7 | 252 | 3 | 19842932 | ||
| Pubmed | RPS3A SRPK2 TUBGCP2 TUBGCP5 PARP1 DDX17 CDC42BPA POLR2B UBR4 AAR2 XPOT | 1.36e-05 | 300 | 252 | 11 | 28561026 | |
| Pubmed | 1.48e-05 | 43 | 252 | 5 | 26030138 | ||
| Pubmed | MANBA IL20RA TXK DNASE2B AGL SYCP1 MKI67 KAT6A LDHAL6B IL1RL1 FUCA2 | 2.02e-05 | 313 | 252 | 11 | 20800603 | |
| Pubmed | 2.05e-05 | 8 | 252 | 3 | 11279518 | ||
| Pubmed | 2.05e-05 | 8 | 252 | 3 | 11784029 | ||
| Pubmed | 2.05e-05 | 8 | 252 | 3 | 11528422 | ||
| Pubmed | 2.05e-05 | 157 | 252 | 8 | 30186101 | ||
| Pubmed | NOLC1 RPS3A PARP1 TCERG1 MKI67 H1-10 DDX17 POLR2B LDHA SCYL2 SMARCA4 MRPS5 ROCK1 | 2.31e-05 | 441 | 252 | 13 | 31239290 | |
| Pubmed | ERCC6 RPS3A TTF1 PTPN12 UBR4 RANBP6 HUWE1 ASH2L EPG5 SCYL2 FMNL3 USP5 KMT2D ROCK1 ASXL2 | 3.12e-05 | 591 | 252 | 15 | 15231748 | |
| Pubmed | GABRB1 GABRB2 GABRB3 NOLC1 FRMPD4 TENM2 REEP2 FAM120C DHX29 DDX17 CDC42BPA DNAJC16 UBR4 ATG2B LASP1 HUWE1 GRM5 LDHA ATP2C1 SLC4A10 MRPS5 SNX1 | 3.29e-05 | 1139 | 252 | 22 | 36417873 | |
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | TBC1D2B SRPK2 SCAF4 DGUOK MKI67 LCMT1 H1-10 POLR2B NPC2 DPP3 LDHA ASH2L PPP6C PREP GALNTL5 XPOT | 3.54e-05 | 670 | 252 | 16 | 22990118 |
| Pubmed | 3.55e-05 | 26 | 252 | 4 | 20731661 | ||
| Pubmed | ERCC6 SRPK2 PIGG TTF1 CASZ1 SCAF4 MED24 WDR75 TCERG1 FAM120C NME2 MBD4 DHX29 CDC42BPA DNAJC16 POLR2B BAZ1B ASH2L CEP164 PCF11 MYOF MRPS23 SMARCA2 MRPS5 PARN KDM1B | 3.80e-05 | 1497 | 252 | 26 | 31527615 | |
| Pubmed | ABCC3 PUS3 RPS3A TUBGCP5 MED24 PARP1 PPIL2 USP1 LCMT1 IPO5 H1-10 POLR2B GNPTAB UBR4 SPG11 ASH2L WDR59 TRIM16 NBAS ATP2C1 PARN SMS BZW1 SLC33A1 | 4.08e-05 | 1327 | 252 | 24 | 32694731 | |
| Pubmed | 4.11e-05 | 224 | 252 | 9 | 32941674 | ||
| Pubmed | TUBGCP2 TUBGCP5 WDR75 AGL NME2 DNA2 DNAJC16 POLR2B ATG2B RANBP6 HUWE1 WDR59 AAR2 MTR XPOT | 4.15e-05 | 606 | 252 | 15 | 36538041 | |
| Pubmed | 4.34e-05 | 10 | 252 | 3 | 16192310 | ||
| Pubmed | 4.34e-05 | 10 | 252 | 3 | 26165599 | ||
| Pubmed | 4.34e-05 | 10 | 252 | 3 | 30289439 | ||
| Pubmed | 4.55e-05 | 129 | 252 | 7 | 23022380 | ||
| Pubmed | LCP1 preferentially binds clasped αMβ2 integrin and attenuates leukocyte adhesion under flow. | PARP1 TCERG1 TECPR1 IPO5 DDX17 UBR4 HUWE1 LDHA PDIA4 MYOF USP5 | 4.76e-05 | 344 | 252 | 11 | 30333137 |
| Pubmed | Genetical genomic determinants of alcohol consumption in rats and humans. | 4.78e-05 | 130 | 252 | 7 | 19874574 | |
| Pubmed | 5.23e-05 | 2 | 252 | 2 | 28986474 | ||
| Pubmed | 5.23e-05 | 2 | 252 | 2 | 20237295 | ||
| Pubmed | 5.23e-05 | 2 | 252 | 2 | 23163725 | ||
| Pubmed | ROCK1 and ROCK2 regulate epithelial polarisation and geometric cell shape. | 5.23e-05 | 2 | 252 | 2 | 22462535 | |
| Pubmed | 5.23e-05 | 2 | 252 | 2 | 26950270 | ||
| Pubmed | 5.23e-05 | 2 | 252 | 2 | 23486367 | ||
| Pubmed | 5.23e-05 | 2 | 252 | 2 | 29800294 | ||
| Pubmed | 5.23e-05 | 2 | 252 | 2 | 15576411 | ||
| Pubmed | 5.23e-05 | 2 | 252 | 2 | 15096457 | ||
| Pubmed | 5.23e-05 | 2 | 252 | 2 | 35203270 | ||
| Pubmed | SMARCA4/SMARCA2-deficient Carcinoma of the Esophagus and Gastroesophageal Junction. | 5.23e-05 | 2 | 252 | 2 | 33027072 | |
| Pubmed | 5.23e-05 | 2 | 252 | 2 | 9489997 | ||
| Pubmed | 5.23e-05 | 2 | 252 | 2 | 22606311 | ||
| Pubmed | Rho-kinase/ROCK: A key regulator of the cytoskeleton and cell polarity. | 5.23e-05 | 2 | 252 | 2 | 20803696 | |
| Pubmed | 5.23e-05 | 2 | 252 | 2 | 30369081 | ||
| Pubmed | 5.23e-05 | 2 | 252 | 2 | 20333683 | ||
| Pubmed | 5.23e-05 | 2 | 252 | 2 | 29464551 | ||
| Pubmed | 5.23e-05 | 2 | 252 | 2 | 12508221 | ||
| Cytoband | 2q12 | 3.47e-05 | 12 | 252 | 3 | 2q12 | |
| Cytoband | 11p15.5-p15.4 | 1.79e-04 | 4 | 252 | 2 | 11p15.5-p15.4 | |
| GeneFamily | Gamma-aminobutyric acid type A receptor subunits | 6.63e-07 | 19 | 167 | 5 | 563 | |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 2.53e-04 | 3 | 167 | 2 | 287 | |
| GeneFamily | CD molecules|I-set domain containing|Immunoglobulin like domain containing|Interleukin receptors|TIR domain containing | 3.25e-04 | 15 | 167 | 3 | 1296 | |
| GeneFamily | Dyneins, axonemal | 4.79e-04 | 17 | 167 | 3 | 536 | |
| GeneFamily | CD molecules|I-set domain containing|Immunoglobulin like domain containing|Interleukin receptors|TIR domain containing | 5.98e-04 | 42 | 167 | 4 | 602 | |
| GeneFamily | Volume regulated anion channel subunits | 8.33e-04 | 5 | 167 | 2 | 1158 | |
| GeneFamily | Glycine receptors | 8.33e-04 | 5 | 167 | 2 | 868 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 1.16e-03 | 50 | 167 | 4 | 1293 | |
| GeneFamily | PHD finger proteins | 1.48e-03 | 90 | 167 | 5 | 88 | |
| GeneFamily | WD repeat domain containing|ERCC excision repair associated | 1.73e-03 | 7 | 167 | 2 | 1268 | |
| GeneFamily | Cytochrome P450 family 3 | 2.29e-03 | 8 | 167 | 2 | 1002 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 3.07e-03 | 206 | 167 | 7 | 682 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | MYO7A RPS3A TBC1D2B PITPNC1 IL18RAP PARP1 TRANK1 GVINP1 SACS USP1 DDX17 POLR2B GNPTAB UBR4 KAT6A HECTD4 BAZ1B RAPGEF1 SPG11 FRYL LASP1 HUWE1 LDHA ZAP70 EPG5 PCF11 FMNL3 KMT2D FAM111A SMARCA2 MTR ROCK1 ASXL2 ATM BZW1 FYN SORL1 PSD4 | 3.56e-08 | 1492 | 251 | 38 | M40023 |
| Coexpression | ENK_UV_RESPONSE_KERATINOCYTE_DN | NOLC1 ERCC5 TUBGCP2 MAP3K5 PARP1 TCERG1 AGL MBD4 USP1 ROCK2 IPO5 DDX17 SLC31A1 POLR2B KAT6A ASH2L PCF11 ATP2C1 SMARCA2 SORL1 | 4.76e-08 | 481 | 251 | 20 | M3898 |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | LAMP5 SRPK2 TTF1 IL18RAP RYR3 MAP3K5 DMXL1 ABCB4 SH3BP4 EFHC1 SACS DGUOK MBD4 USP1 IPO5 CRELD2 DPP3 LRRC8D WDR59 BTBD3 SCYL2 ATP2C1 PPP6C MTR ROCK1 ASXL2 ATM BZW1 FYN SLC33A1 EPHB1 | 7.13e-07 | 1215 | 251 | 31 | M41122 |
| Coexpression | SCHERER_PBMC_APSV_WETVAX_AGE_18_32YO_5_TO_7DY_DN | RPS3A SRPK2 IL18RAP TXK NELL2 COL21A1 DGUOK KAT6A ZAP70 PPP6C SORL1 | 2.17e-06 | 188 | 251 | 11 | M40862 |
| Coexpression | GSE8685_IL2_STARVED_VS_IL2_ACT_IL2_STARVED_CD4_TCELL_DN | CPNE2 GABRP TBC1D2B HPSE TBC1D32 AGL DOCK1 SLC31A1 CRELD2 FAM111A FUCA2 | 3.58e-06 | 198 | 251 | 11 | M325 |
| Coexpression | GSE3920_IFNA_VS_IFNB_TREATED_ENDOTHELIAL_CELL_DN | PDE1A IL18RAP GNPTAB KAT6A RAPGEF1 FRYL LASP1 KCNK10 IL1RL1 FYN | 4.87e-06 | 166 | 251 | 10 | M6701 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | SRPK2 PTPN12 SACS GLRB DOCK1 ROCK2 ATRN DDX17 CDC42BPA POLR2B KAT6A BAZ1B SPG11 FRYL PCF11 NBAS MYOF ATP2C1 SMARCA2 MTR ROCK1 PARN FYN | 9.34e-06 | 856 | 251 | 23 | M4500 |
| Coexpression | GSE7568_IL4_VS_IL4_AND_DEXAMETHASONE_TREATED_MACROPHAGE_DN | 1.59e-05 | 151 | 251 | 9 | M369 | |
| Coexpression | NAKAYA_MONOCYTE_FLUMIST_AGE_18_50YO_7DY_UP | NOLC1 SRPK2 DMXL1 PTPN12 EFHC1 LCMT1 IPO5 GNPTAB UBR4 HECTD4 LRRC8D PCF11 MTR TTC17 ATM FYN | 1.64e-05 | 477 | 251 | 16 | M40930 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | ERCC5 DMXL1 SACS MKI67 MBD4 USP1 DHX29 IPO5 CDC42BPA GNPTAB BAZ1B SPG11 PIEZO2 FAM111A SMARCA2 MTR SMS ATM SORL1 | 2.08e-05 | 656 | 251 | 19 | M18979 |
| Coexpression | GSE3920_IFNA_VS_IFNG_TREATED_FIBROBLAST_UP | 5.08e-05 | 175 | 251 | 9 | M6690 | |
| Coexpression | YAMASHITA_LIVER_CANCER_STEM_CELL_DN | 9.07e-05 | 76 | 251 | 6 | M9206 | |
| Coexpression | GSE11057_EFF_MEM_VS_CENT_MEM_CD4_TCELL_DN | 9.20e-05 | 189 | 251 | 9 | M3112 | |
| Coexpression | RATTENBACHER_BOUND_BY_CELF1 | NFASC PIGG DMXL1 MYO5C CFAP54 DDX17 RANBP6 FRYL HUWE1 WDR59 PIEZO2 SMARCA2 LRRC8A TTC17 | 1.07e-04 | 444 | 251 | 14 | M2505 |
| Coexpression | ERWIN_COHEN_BLOOD_LIVE_VACCINE_TC_83_AGE_23_48YO_VACCINATED_VS_CONTROL_14DY_UP | DMXL1 KLRF1 TCERG1 SACS AGL PXYLP1 DDHD2 NME2 USP1 RANBP6 PPA1 ZDHHC20 MTR ATM BZW1 FYN SLC33A1 XPOT | 1.23e-04 | 687 | 251 | 18 | M41022 |
| Coexpression | GSE24972_WT_VS_IRF8_KO_SPLEEN_FOLLICULAR_BCELL_UP | 1.26e-04 | 197 | 251 | 9 | M8092 | |
| Coexpression | GSE22025_UNTREATED_VS_TGFB1_AND_PROGESTERONE_TREATED_CD4_TCELL_DN | 1.26e-04 | 197 | 251 | 9 | M8386 | |
| Coexpression | GSE21063_3H_VS_16H_ANTI_IGM_STIM_BCELL_DN | 1.26e-04 | 197 | 251 | 9 | M8271 | |
| Coexpression | GSE32986_GMCSF_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_DN | 1.31e-04 | 198 | 251 | 9 | M8624 | |
| Coexpression | GSE29618_LAIV_VS_TIV_FLU_VACCINE_DAY7_PDC_UP | 1.31e-04 | 198 | 251 | 9 | M5018 | |
| Coexpression | GSE22282_HYPOXIA_VS_NORMOXIA_MYELOID_DC_DN | 1.36e-04 | 199 | 251 | 9 | M8065 | |
| Coexpression | GSE3982_CTRL_VS_IGE_STIM_MAST_CELL_UP | 1.36e-04 | 199 | 251 | 9 | M5365 | |
| Coexpression | GSE41867_DAY6_EFFECTOR_VS_DAY30_EXHAUSTED_CD8_TCELL_LCMV_CLONE13_DN | 1.41e-04 | 200 | 251 | 9 | M9490 | |
| Coexpression | GSE14908_RESTING_VS_HDM_STIM_CD4_TCELL_ATOPIC_PATIENT_UP | 1.41e-04 | 200 | 251 | 9 | M7077 | |
| Coexpression | GSE19888_ADENOSINE_A3R_INH_PRETREAT_AND_ACT_BY_A3R_VS_A3R_INH_AND_TCELL_MEMBRANES_ACT_MAST_CELL_DN | 1.41e-04 | 200 | 251 | 9 | M7353 | |
| Coexpression | GSE8835_CD4_VS_CD8_TCELL_UP | 1.41e-04 | 200 | 251 | 9 | M6254 | |
| Coexpression | GSE25123_WT_VS_PPARG_KO_MACROPHAGE_IL4_STIM_DN | ZDHHC2 HPSE IL18RAP MKI67 RASGEF1A BTBD3 FAM111A IL1RL1 FUCA2 | 1.41e-04 | 200 | 251 | 9 | M7958 |
| Coexpression | GSE33162_UNTREATED_VS_4H_LPS_STIM_HDAC3_KO_MACROPHAGE_DN | 1.41e-04 | 200 | 251 | 9 | M9037 | |
| Coexpression | GSE8621_LPS_PRIMED_UNSTIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_DN | 1.41e-04 | 200 | 251 | 9 | M6975 | |
| Coexpression | HSIAO_LIVER_SPECIFIC_GENES | 1.55e-04 | 249 | 251 | 10 | M13283 | |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | MAP3K5 SACS MKI67 USP1 KAT6A BAZ1B FRYL BTBD3 PCF11 MTMR6 FYN | 1.62e-04 | 300 | 251 | 11 | M8702 |
| Coexpression | BLALOCK_ALZHEIMERS_DISEASE_DN | GABRB3 NOLC1 KIF1B ACOT7 SRPK2 REEP2 PARP1 NELL2 TCERG1 SACS PTPRR DGUOK GLRB NME2 MOCS2 ROCK2 IPO5 ATRN POLR2B PPA1 LDHA ASH2L ATP2C1 GNA14 PREP SMARCA2 | 1.77e-04 | 1248 | 251 | 26 | M17728 |
| Coexpression | BENPORATH_MYC_MAX_TARGETS | ERCC6 SLC26A4 CDKL3 MAP3K5 SHPK MBD4 USP1 MOCS2 IPO5 DDX17 SLC31A1 BAZ1B PPA1 LDHA ASH2L PCF11 PPP6C PREP ATM | 1.87e-04 | 775 | 251 | 19 | M17753 |
| Coexpression | LI_WILMS_TUMOR_VS_FETAL_KIDNEY_1_DN | 1.91e-04 | 164 | 251 | 8 | M13108 | |
| Coexpression | GSE37563_WT_VS_CTLA4_KO_CD4_TCELL_D4_POST_IMMUNIZATION_UP | 2.08e-04 | 166 | 251 | 8 | M9015 | |
| Coexpression | NAKAYA_B_CELL_FLUMIST_AGE_18_50YO_7DY_UP | PIGG TTF1 SCAF4 ABCB4 GVINP1 FAM120C AGL LCMT1 FRYL HUWE1 WDR59 PCF11 PDIA4 ATM | 2.15e-04 | 475 | 251 | 14 | M40979 |
| Coexpression | LUCAS_HNF4A_TARGETS_UP | 2.34e-04 | 58 | 251 | 5 | M11410 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | GABRB2 FRMPD4 RYR3 TRANK1 OTOGL DNAH9 FAT4 APOB DNAH1 PIEZO2 XIRP2 MYO15A DNAH11 | 4.83e-11 | 184 | 252 | 13 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | GABRB2 FRMPD4 RYR3 TRANK1 OTOGL DNAH9 FAT4 APOB DNAH1 PIEZO2 XIRP2 MYO15A DNAH11 | 4.83e-11 | 184 | 252 | 13 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | GABRB2 FRMPD4 RYR3 TRANK1 OTOGL DNAH9 FAT4 APOB DNAH1 PIEZO2 XIRP2 MYO15A DNAH11 | 4.83e-11 | 184 | 252 | 13 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | COVID_non-vent-Lymphocytic-ILC-NK_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | IL18RAP TXK KLRF1 PTPN12 TRANK1 GNPTAB ZAP70 SLFN13 ATM FYN SORL1 | 1.99e-08 | 199 | 252 | 11 | ed35d747f11f6ea6a5cb7061057f0a98d9e0db99 |
| ToppCell | COVID_non-vent-Lymphocytic-ILC|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | IL18RAP TXK KLRF1 PTPN12 TRANK1 GNPTAB ZAP70 SLFN13 ATM FYN SORL1 | 1.99e-08 | 199 | 252 | 11 | df4f7d5be099e3e6054f3b812ccf70251664e4c0 |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | IL18RAP KLRF1 PTPN12 TRANK1 FAT4 GNPTAB RAPGEF1 HUWE1 ZAP70 SLFN13 PSD4 | 2.09e-08 | 200 | 252 | 11 | 2281debd86e5d92e8fe0397aec9ef670800f7471 |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-Hepatocyte_(Periportal)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.47e-08 | 175 | 252 | 10 | 5c38d4b6c03473d841e6203a7efaa6dcb2d59386 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_ILC|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.27e-07 | 188 | 252 | 10 | 9abd78970bbe4ed03b59a83da63bbd334712f605 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_ILC-NK_cell|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.27e-07 | 188 | 252 | 10 | 5ae8ccdd328cf117da1d01ced2c3b7f763a5f1f1 | |
| ToppCell | LPS-IL1RA-Endothelial-Mes-Like-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.47e-07 | 145 | 252 | 9 | 90ca38c02325c5c637c32efdef634b54cc3cd105 | |
| ToppCell | healthy_donor-Lymphocytic-ILC-NK_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | 2.05e-07 | 198 | 252 | 10 | d7053a898e04478c577381085f615edaad3cdc5b | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | GABRB2 GABRB3 FRMPD4 TENM2 NELL2 PTPRR ROCK2 GRM5 SLC4A10 PRKCE | 2.05e-07 | 198 | 252 | 10 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 |
| ToppCell | healthy_donor-Lymphocytic-ILC|healthy_donor / Disease condition, Lineage, Cell class and subclass | 2.05e-07 | 198 | 252 | 10 | aa33be29e26f1b8facfc894413099083ae3bbb1b | |
| ToppCell | COVID-19_Severe-NK_CD56bright|World / disease group, cell group and cell class | 2.89e-07 | 157 | 252 | 9 | 9dcbabb377da7e93ec9f9abf09576a92877a7e02 | |
| ToppCell | Bronchial_Biopsy-Immune-T_and_NK|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 5.13e-07 | 168 | 252 | 9 | 435b2f238fbb3f50427e8cdecf2220615015153c | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.39e-07 | 169 | 252 | 9 | 8bca402e144819cb9a8d431d6bf9429be2fff6d6 | |
| ToppCell | COVID-19-kidney-NK|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.56e-07 | 181 | 252 | 9 | 8906ee8a7a1616dfe8c3b5c73988416641213629 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-lymphocytic-innate_lymphocytic-mature_NK_T_cell|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.25e-06 | 187 | 252 | 9 | 6981b856187a2e689260ecb7d0a1193a374ee9b9 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.31e-06 | 188 | 252 | 9 | f7dc29dfec68236883469e848be5db34f5526d6b | |
| ToppCell | Children_(3_yrs)-Immune-natural_killer_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.49e-06 | 191 | 252 | 9 | 9b8b64a36e27a2523b8730c7922fd7ad865a021e | |
| ToppCell | IPF-Lymphoid-NK|World / Disease state, Lineage and Cell class | 1.49e-06 | 191 | 252 | 9 | f206159b9d5e84cf14a65bfdc008895cec5a8081 | |
| ToppCell | Immune-natural_killer_cell|World / Lineage, Cell type, age group and donor | 1.56e-06 | 192 | 252 | 9 | 68121a6ef4115a93d87aad8802ef9b27d793d8c0 | |
| ToppCell | Children_(3_yrs)-Immune-natural_killer_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.63e-06 | 193 | 252 | 9 | 1cb666375bc4e1b11a146d20896c9b5ae6fd0887 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Bcl6|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 1.69e-06 | 144 | 252 | 8 | 08005be9e3367f78ef27e125d9cce5ca53f4bd2d | |
| ToppCell | 10x5'-blood-Lymphocytic_NK-NK_CD16|blood / Manually curated celltypes from each tissue | 1.70e-06 | 194 | 252 | 9 | c34a32f1cfe3e597cb0f91ba5bdd3e114e9f3d2e | |
| ToppCell | 3'_v3-Lung-Lymphocytic_NK-NK_CD16|Lung / Manually curated celltypes from each tissue | 1.70e-06 | 194 | 252 | 9 | 3337042eef91a49f621058785723228cf4dfdad4 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_NK-NK_CD16|bone_marrow / Manually curated celltypes from each tissue | 1.70e-06 | 194 | 252 | 9 | 7773501e076d470158dbc1d7f10c67152b326eb7 | |
| ToppCell | 10x5'-blood-Lymphocytic_NK|blood / Manually curated celltypes from each tissue | 1.77e-06 | 195 | 252 | 9 | c1db871e8e8e8b8d6a5798bc43eaf54e102b75eb | |
| ToppCell | control-Lymphoid-Treg|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.77e-06 | 195 | 252 | 9 | 66959ae839eb60a573da06bdd227090ebb5bb9ed | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK-natural_killer_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.93e-06 | 197 | 252 | 9 | 550cce374332c49893bcf4ce4b7dceb7f5fe26aa | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.98e-06 | 147 | 252 | 8 | 8f725ff8fb4ced5db2643e80669d3f7945b820ab | |
| ToppCell | mild_COVID-19_(asymptomatic)-NK|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 2.01e-06 | 198 | 252 | 9 | 1e43181c13e054570046c7a973ddc1c586e259b0 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK-natural_killer_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.01e-06 | 198 | 252 | 9 | 5607e36f393cb399fcc2504502498453fd32d96b | |
| ToppCell | severe_COVID-19-NK|severe_COVID-19 / disease group, cell group and cell class (v2) | 2.01e-06 | 198 | 252 | 9 | 7f51e37516f717e424190e6584f1c74d357e2da4 | |
| ToppCell | severe-NK|severe / disease stage, cell group and cell class | 2.01e-06 | 198 | 252 | 9 | cb505077dc5bdf3fdd513bb9032e32bb9644c004 | |
| ToppCell | COVID-19_Moderate-NK|COVID-19_Moderate / disease group, cell group and cell class | 2.10e-06 | 199 | 252 | 9 | e0e83ba511957be9ad3413460dcb6b7d7b65dd18 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK-NK|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.18e-06 | 200 | 252 | 9 | 7d90fcb5dfc4c9d562c93b0f9293ed12b5f4f404 | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-NK-ILC|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.18e-06 | 200 | 252 | 9 | d2422aaf807010194994db97142b9fd2e807312d | |
| ToppCell | Control-Control-Lymphocyte-T/NK-NK|Control / Disease, condition lineage and cell class | 2.18e-06 | 200 | 252 | 9 | c64c27dbf4df42ca2ad2bd94b50fab87b4050ef3 | |
| ToppCell | mild-NK|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.18e-06 | 200 | 252 | 9 | a11fb1d7e124c352eb73fea0e0ec0fed577c97f7 | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK-NK|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.18e-06 | 200 | 252 | 9 | 0f8e2fed93cc103b20a825d8d3e83787c5c015cc | |
| ToppCell | Parenchymal-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.18e-06 | 200 | 252 | 9 | 1d2ee63010b7b8b38bea7d3b30eebfbcdd18b967 | |
| ToppCell | facs-Heart-Unknown-3m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.23e-06 | 157 | 252 | 8 | 8a393eece90fb9a1b7c356736bdb36277261fbd3 | |
| ToppCell | facs-Heart-Unknown-3m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.23e-06 | 157 | 252 | 8 | 8d30d8e6fae93afcada6bd68799439335cd65b69 | |
| ToppCell | facs-Heart-Unknown-3m-Myeloid|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.23e-06 | 157 | 252 | 8 | 2ac4695d9e4ca8d4ba19c555e9a1d86ac8f398ab | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Tshz2-Excitatory_Neuron.Slc17a7-Slc17a6.Tshz2-Npnt_(Retrosplenial_areas,_layer_5,_Npnt+)|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.37e-06 | 41 | 252 | 5 | b1e70962de91a747ec718a3fad4247fd0cb7d9a8 | |
| ToppCell | Posterior_cortex-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Tshz2-Excitatory_Neuron.Slc17a7-Slc17a6.Tshz2-Npnt_(Retrosplenial_areas,_layer_5,_Npnt+)-|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 3.37e-06 | 41 | 252 | 5 | 16dbb13baa47c4db80ddd83ac36aad6c43b5461a | |
| ToppCell | COVID-19_Severe-NK_CD56bright|COVID-19_Severe / disease group, cell group and cell class | 3.55e-06 | 159 | 252 | 8 | 9e2067f0d76769717f7048dab505fadd36bbb83e | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 4.26e-06 | 163 | 252 | 8 | 19c28ce16a588a7f4a035c32726f6ccd67702b5b | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 5.33e-06 | 168 | 252 | 8 | 6db453cbbbaf4144a86fadcfa5805d33396713b5 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.33e-06 | 168 | 252 | 8 | b98af4043dfa5dfa4413e482879fad88de484675 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.33e-06 | 168 | 252 | 8 | 073b53d4cee6bc8c5c6fce51cf6cd9c316478f69 | |
| ToppCell | droplet-Liver-HEPATOCYTES|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.57e-06 | 169 | 252 | 8 | f195467438c589f87224bde7da720dea072d110c | |
| ToppCell | Control-Lymphocyte-T_NK-MAIT|Control / Disease, Lineage and Cell Type | 5.57e-06 | 169 | 252 | 8 | 8c2aac193a9c500f01a99a2ee530839c851b6222 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.57e-06 | 169 | 252 | 8 | 7785cab967a33560830c394c918d6ce625103858 | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_C|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 5.81e-06 | 170 | 252 | 8 | 81341bf4fe090af70b2091b6b2579ed08d76e22d | |
| ToppCell | 356C-Lymphocytic-NK_cells-NK_cell_E|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 6.61e-06 | 173 | 252 | 8 | 090dc3c5bd2652a65c2490fc889da858c3af368f | |
| ToppCell | PND28-Immune-Immune_Myeloid-DC-cDC1-cDC1_prolif|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.48e-06 | 179 | 252 | 8 | 9dea57494d59abd6e8abf34e31faf53462ea0fa0 | |
| ToppCell | Mild-Lymphoid-T-innate_T|Mild / Condition, Lineage, Cell class and cell subclass | 8.48e-06 | 179 | 252 | 8 | abc0fbe101a464a2c85755a974a3d5c2b968fe46 | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_NK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 8.83e-06 | 180 | 252 | 8 | 1c8398342d3fa4d5ca9a8a63626cc497c5291446 | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_NK-T_NK-CD56_bright_NK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 8.83e-06 | 180 | 252 | 8 | ddbab26b05f057bd78b78773381cd447bd2e2726 | |
| ToppCell | 10x3'2.3-week_17-19-Lymphocytic_NK-T_NK|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 8.83e-06 | 180 | 252 | 8 | 0a98d21fec67a890e75ebf0e2d23adddd77da214 | |
| ToppCell | Adult-Immune-natural_killer_cell-D231|Adult / Lineage, Cell type, age group and donor | 9.58e-06 | 182 | 252 | 8 | dbf47bf4754d8ec3bc3ab1d5be7a6c47a7afbf43 | |
| ToppCell | droplet-Thymus-nan-3m-Lymphocytic-Double_negative_Thymocyte,_DN4_(Cd8-,_Cd4-),_some_undergoing_VDJ_recombination_|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.97e-06 | 183 | 252 | 8 | a0a3e4d07ac73dbbb1e019fd11e88ccffe6cf2ca | |
| ToppCell | facs-Spleen-nan-3m-Lymphocytic-CD4-positive,_alpha-beta_T_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-05 | 184 | 252 | 8 | c37c623c4a5ff1628486d8a6461fa355ad5c264c | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.04e-05 | 184 | 252 | 8 | d48807f9da48bdd015a54c606d2e2a311f181396 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Epithelial-neuroepithelial_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-05 | 185 | 252 | 8 | 05bc89a566b0db90ae06506e067190a4739a0974 | |
| ToppCell | Control-T_cells-NK_cells|Control / group, cell type (main and fine annotations) | 1.08e-05 | 185 | 252 | 8 | 755c0998c729f462399f1d5e88adf4bfae31be30 | |
| ToppCell | droplet-Thymus-nan-3m-Lymphocytic-double_negative_T_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-05 | 186 | 252 | 8 | 11929e36d8c9b4c4bc2f5e912f139f474f91ab00 | |
| ToppCell | Control-Lymphoid-ILC_A|World / Disease state, Lineage and Cell class | 1.12e-05 | 186 | 252 | 8 | 7bc939bf4e71bb4c6409b862c1f6c547d775e089 | |
| ToppCell | Control-T_cells|Control / group, cell type (main and fine annotations) | 1.17e-05 | 187 | 252 | 8 | f4e8e0eba58da89b56587667555a5d4754e108c7 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T2|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.17e-05 | 187 | 252 | 8 | f3e37c18ac6471c7992609bbddfa4975571c815c | |
| ToppCell | CF-Lymphoid-T_cell_&_NK_cell|Lymphoid / Disease state, Lineage and Cell class | 1.21e-05 | 188 | 252 | 8 | 15057036b46c9df621ec4955aa94ca3036245d45 | |
| ToppCell | COPD-Lymphoid-NK|COPD / Disease state, Lineage and Cell class | 1.21e-05 | 188 | 252 | 8 | c9a227c8e71b69929d43e9afb8306a95c8163778 | |
| ToppCell | Fetal_29-31_weeks-Immune-natural_killer_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.21e-05 | 188 | 252 | 8 | 6686dbba990066568aa7573e70a7db8b4758f457 | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-Treg_cell_1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.21e-05 | 188 | 252 | 8 | b1ec7c45aedcc3d22cac898c6a3679e7f8b44c77 | |
| ToppCell | COPD-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 1.21e-05 | 188 | 252 | 8 | 186fe1ea328c942910190a4240262c0d8642ea3b | |
| ToppCell | Healthy_donor-NK_CD56bright|World / disease group, cell group and cell class (v2) | 1.21e-05 | 188 | 252 | 8 | 8ee359199c61c3b5b498ac35148390db5cc1a836 | |
| ToppCell | Fetal_29-31_weeks-Immune-natural_killer_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.26e-05 | 189 | 252 | 8 | c604da558c9f4055fb36218452463539f2a73223 | |
| ToppCell | Hippocampus-Neuronal-Excitatory|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.26e-05 | 189 | 252 | 8 | 4b90d181eb0a42814eeb23bc82e52fd3a12392a7 | |
| ToppCell | Healthy_donor-NK_CD56bright|Healthy_donor / disease group, cell group and cell class (v2) | 1.26e-05 | 189 | 252 | 8 | 9eac380a3bb4b685effb52d816e1960972660646 | |
| ToppCell | COVID-19-kidney-NK|kidney / Disease (COVID-19 only), tissue and cell type | 1.31e-05 | 190 | 252 | 8 | e3ca3c9fb9e27670a5dd128dd6564ff98a57159e | |
| ToppCell | COVID-19-T_cells|COVID-19 / group, cell type (main and fine annotations) | 1.36e-05 | 191 | 252 | 8 | 7f64add931b64b8d35836fa6bee9ebab593844d3 | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 1.36e-05 | 191 | 252 | 8 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.41e-05 | 192 | 252 | 8 | 6a252e298f8a454623fa9c1c893a7a45a886d694 | |
| ToppCell | facs-Liver-Hepatocytes-3m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-05 | 139 | 252 | 7 | 4ddfbc36a0560fb70594627178bff652ab1ea3e9 | |
| ToppCell | facs-Liver-Hepatocytes-3m-Epithelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-05 | 139 | 252 | 7 | 82bf5ba69a907fbd9b4e2b2dd1dd27b8c4c75f25 | |
| ToppCell | facs-Liver-Hepatocytes-3m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-05 | 139 | 252 | 7 | fc9ac09c2106e88104a52575832d71d17765eec8 | |
| ToppCell | facs-Liver-Hepatocytes-3m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.45e-05 | 139 | 252 | 7 | fc4b39ac9a10cf0acacfebbc4295edf324d930d5 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_NK|lymph-node_spleen / Manually curated celltypes from each tissue | 1.47e-05 | 193 | 252 | 8 | e325cf49e159c6be205ed93adaa09efdd0c122b4 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 1.47e-05 | 193 | 252 | 8 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.47e-05 | 193 | 252 | 8 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_NK|bone_marrow / Manually curated celltypes from each tissue | 1.47e-05 | 193 | 252 | 8 | e790ab76c12f74a13936c231076f1e397283efb3 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_NK|Lung / Manually curated celltypes from each tissue | 1.47e-05 | 193 | 252 | 8 | a98ee519e0da93ae4a2dcdda1ee8b4138dec131b | |
| ToppCell | COVID-19-lung-NK/NKT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.47e-05 | 193 | 252 | 8 | c24b44fcc92fff42ebba6f1aff91c7aaea179e56 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.52e-05 | 194 | 252 | 8 | a44be2f021cfdd0fcdc698c3f04d66db7a1aa6c2 | |
| ToppCell | COVID-19-lung-NK_cells|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.52e-05 | 194 | 252 | 8 | 4c92f18e0a34fb50630d4b260eaf179202508b6d | |
| ToppCell | 10x5'-Liver-Lymphocytic_NK|Liver / Manually curated celltypes from each tissue | 1.52e-05 | 194 | 252 | 8 | 0b78f4ed84bbaca9f72f005c16c7492bb01d4328 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_NK-NK_CD16|lymph-node_spleen / Manually curated celltypes from each tissue | 1.58e-05 | 195 | 252 | 8 | e756733cf48768bf40058d6cf9039e52f7563133 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.58e-05 | 195 | 252 | 8 | 2e1df01bf6e4e98e6cd9fb50926e34c5077b8666 | |
| Computational | Neurotransmitter (GABA) receptor. | 5.14e-08 | 15 | 164 | 6 | MODULE_215 | |
| Computational | Ion channels. | 4.79e-05 | 27 | 164 | 5 | MODULE_214 | |
| Drug | 5 beta-pregnanediol | GABRB1 GABRB2 GABRB3 GABRP ABCC3 CYP3A7 CYP3A4 GABRQ HNF4A ABCC2 | 9.91e-10 | 60 | 250 | 10 | CID000012547 |
| Drug | sevoflurane | GABRB1 GABRB2 GABRB3 GABRP GABRQ RYR1 RYR3 GLRA2 GLRB ATP2C1 PRKCE | 2.25e-08 | 105 | 250 | 11 | CID000005206 |
| Drug | 3-isothujone | 2.90e-08 | 30 | 250 | 7 | CID000011027 | |
| Drug | magnesium | LDHAL6A MYO7A TRPC6 DNAL1 RYR1 RYR3 MYO5C ABCB4 NT5C1A DGUOK C1S NME2 DNAH9 GPLD1 KIF13B PDPR POLR2B LDHAL6B CASQ2 AASDH DPP3 PPA1 GRM5 LDHA ZAP70 DNAH1 MRPL17 ATP2C1 GUCY2C CTDP1 PRKACG MTR ROCK1 PRKCE PARN MAPK11 FYN DNAH11 | 5.51e-08 | 1325 | 250 | 38 | CID000000888 |
| Drug | felbamate | 7.29e-08 | 70 | 250 | 9 | CID000003331 | |
| Drug | isoflurane | GABRB1 GABRB2 GABRB3 GABRP LDHAL6A GABRQ RYR1 RYR3 GLRA2 GLRB LDHAL6B GRM5 LDHA ATP2C1 KCNK10 MAPK11 | 8.84e-08 | 279 | 250 | 16 | CID000003763 |
| Drug | propofol | GABRB1 GABRB2 GABRB3 GABRP LDHAL6A GABRQ RYR1 RYR3 IL1RAPL2 GLRA2 GLRB LDHAL6B LDHA | 2.08e-07 | 191 | 250 | 13 | CID000004943 |
| Drug | V-X-A | 3.16e-07 | 26 | 250 | 6 | CID006369389 | |
| Drug | 5 beta-alphaxalone | 3.44e-07 | 42 | 250 | 7 | CID000068930 | |
| Drug | orthovanadate | ABCC3 PDE1A MYO7A KIF1B DNAL1 RYR1 ABCB4 PTPN12 DNAH9 NR0B2 GPLD1 KIF13B PPA1 GRM5 DNAH1 ATP2C1 PRKACG PRKCE DNAH11 | 3.86e-07 | 435 | 250 | 19 | CID000061672 |
| Drug | halothane | GABRB1 GABRB2 GABRB3 GABRP CYP3A7 CYP3A4 GABRQ RYR1 RYR3 GLRA2 GLRB GRM5 PDIA4 ATP2C1 KCNK10 PRKCE | 4.38e-07 | 314 | 250 | 16 | CID000003562 |
| Drug | riluzole | GABRB1 GABRB2 GABRB3 GABRP GABRQ NFASC RYR1 RYR3 GLRA2 GLRB GRM5 KCNK10 | 5.35e-07 | 174 | 250 | 12 | CID000005070 |
| Drug | BAPTA | GABRB2 GABRP TRPC6 TRPM2 GABRQ RYR1 RYR3 PTPN12 SACS GPLD1 GRM5 PDIA4 ATP2C1 PRKACG PRKCE MAPK11 | 6.64e-07 | 324 | 250 | 16 | CID000104751 |
| Drug | enflurane | 7.91e-07 | 68 | 250 | 8 | CID000003226 | |
| Drug | dihydroxyaflavinine | 8.52e-07 | 17 | 250 | 5 | CID000156857 | |
| Drug | Methoxsalen | 8.88e-07 | 48 | 250 | 7 | ctd:D008730 | |
| Drug | N-methyl-DL-aspartic acid | GABRB1 GABRB2 GABRB3 GABRP EPO LDHAL6A GABRQ RYR1 RYR3 PARP1 GLRA2 GLRB ATRN GNPTAB LDHAL6B TECTA GRM5 LDHA PDIA4 GUCY2C PRKACG PRKCE FYN | 1.05e-06 | 655 | 250 | 23 | CID000004376 |
| Drug | etomidate | 1.11e-06 | 71 | 250 | 8 | CID000036339 | |
| Drug | vanadyl | PDE1A MYO7A DNAL1 MAP3K5 PTPN12 DNAH9 NR0B2 GPLD1 PPA1 DNAH1 PRKACG PRKCE MAPK11 FYN DNAH11 | 1.70e-06 | 307 | 250 | 15 | CID000061671 |
| Drug | triazolam | 2.02e-06 | 54 | 250 | 7 | CID000005556 | |
| Drug | R 5135 | 2.70e-06 | 21 | 250 | 5 | CID000119544 | |
| Drug | Chenodeoxycholic Acid | 2.83e-06 | 107 | 250 | 9 | ctd:D002635 | |
| Drug | clonazepam | 3.34e-06 | 82 | 250 | 8 | CID000002802 | |
| Drug | nifedipine | CYP3A7 LDHAL6A CYP3A4 TRPC6 HEPH RYR1 RYR3 MKI67 ROCK2 LDHAL6B NPC2 GRM5 LDHA ATP2C1 PRKACG ROCK1 PRKCE | 3.81e-06 | 415 | 250 | 17 | CID000004485 |
| Drug | lithocholyltaurine | ABCC3 LDHAL6A ABCB4 PARP1 TCERG1 HPX ABCC2 LDHAL6B LDHA SLC10A1 PRKCE | 3.95e-06 | 175 | 250 | 11 | CID000010595 |
| Drug | zaleplon | 3.98e-06 | 39 | 250 | 6 | CID000005719 | |
| Drug | Lovastatin | ERCC5 ERCC6 CYP3A4 MKI67 ABCC2 IPO5 SLC31A1 APOB LASP1 PDIA4 USP5 ATM | 4.06e-06 | 211 | 250 | 12 | ctd:D008148 |
| Drug | physcione | 4.41e-06 | 11 | 250 | 4 | ctd:C008905 | |
| Drug | cariporide | 4.79e-06 | 86 | 250 | 8 | CID000151172 | |
| Drug | macitentan | 5.19e-06 | 4 | 250 | 3 | ctd:C533860 | |
| Drug | AC1Q6O8B | 5.38e-06 | 41 | 250 | 6 | CID000000334 | |
| Drug | methohexital | 5.50e-06 | 24 | 250 | 5 | CID000009034 | |
| Drug | SL 75102 | 5.50e-06 | 24 | 250 | 5 | CID005751746 | |
| Drug | phenylpyruvic acid | 5.80e-06 | 63 | 250 | 7 | CID000000997 | |
| Drug | sodium | GABRB1 GABRB2 GABRB3 GABRP ABCC3 LDHAL6A SLC26A4 TRPC6 TRPM2 GABRQ RYR1 RYR3 SLC8B1 SACS ABCC2 LDHAL6B CASQ2 PPA1 HUWE1 LDHA ATP2C1 SLC10A1 GUCY2C SLC17A1 PRKACG MTR PRKCE | 5.81e-06 | 944 | 250 | 27 | CID000000923 |
| Drug | taurodeoxycholate | 6.45e-06 | 64 | 250 | 7 | CID000010594 | |
| Drug | U74500A | 6.56e-06 | 12 | 250 | 4 | CID000107964 | |
| Drug | pregnanolone | 6.74e-06 | 90 | 250 | 8 | CID000031402 | |
| Drug | zolpidem | 7.16e-06 | 43 | 250 | 6 | CID000005732 | |
| Drug | picrotoxinine | 7.16e-06 | 65 | 250 | 7 | CID000004816 | |
| Drug | lindane | GABRB1 GABRB2 GABRB3 GABRP CYP3A7 CYP3A4 GABRQ RYR1 RYR3 DOCK1 | 8.19e-06 | 154 | 250 | 10 | CID000000727 |
| Drug | TPMPA | 9.39e-06 | 45 | 250 | 6 | CID000005520 | |
| Drug | pitrazepin | 1.02e-05 | 27 | 250 | 5 | CID000146222 | |
| Drug | Pyrazinamide | 1.02e-05 | 27 | 250 | 5 | ctd:D011718 | |
| Drug | oxalate | LDHAL6A SLC26A4 RYR1 RYR3 LDHAL6B CASQ2 LDHA ATP2C1 MAPK11 IL26 | 1.03e-05 | 158 | 250 | 10 | CID000000971 |
| Drug | thymol | 1.07e-05 | 46 | 250 | 6 | CID000006989 | |
| Drug | heptachlor epoxide | 1.07e-05 | 46 | 250 | 6 | CID000013930 | |
| Drug | Tetramisole hydrochloride [16595-80-5]; Down 200; 16.6uM; MCF7; HT_HG-U133A | GABRB2 TBC1D2B FAM120C DNA2 ATRN KAT6A BAZ1B MYOF MTMR6 ATM MAPK11 | 1.11e-05 | 195 | 250 | 11 | 4412_DN |
| Drug | AP-5 | 1.23e-05 | 128 | 250 | 9 | CID000001216 | |
| Drug | Lindane | 1.29e-05 | 5 | 250 | 3 | DB00431 | |
| Drug | spirobishexahydropyrimidine | 1.29e-05 | 5 | 250 | 3 | CID000100750 | |
| Drug | AC1O5TJF | 1.29e-05 | 5 | 250 | 3 | CID006440410 | |
| Drug | 1,4-diethoxybutane | 1.29e-05 | 5 | 250 | 3 | CID000232578 | |
| Drug | S-lac-NAD | 1.29e-05 | 5 | 250 | 3 | CID000194292 | |
| Drug | sorbarin | 1.29e-05 | 5 | 250 | 3 | CID009824100 | |
| Drug | AC1O5ZB9 | 1.29e-05 | 5 | 250 | 3 | CID006443605 | |
| Drug | AC1L49DG | 1.29e-05 | 5 | 250 | 3 | CID000152931 | |
| Drug | N-trifluoroacetyl-glycine | 1.29e-05 | 5 | 250 | 3 | CID000136227 | |
| Drug | acetylphosphonic acid | 1.29e-05 | 5 | 250 | 3 | CID000081311 | |
| Drug | NSC-60195 | 1.29e-05 | 5 | 250 | 3 | CID000020481 | |
| Drug | ethyl gossypol | 1.29e-05 | 5 | 250 | 3 | CID000374353 | |
| Drug | oxyayanin A | 1.29e-05 | 5 | 250 | 3 | CID005281676 | |
| Drug | B-HAD | 1.29e-05 | 5 | 250 | 3 | CID000131338 | |
| Drug | SQ 31,486 | 1.29e-05 | 5 | 250 | 3 | CID000130015 | |
| Drug | BMS-188107 | 1.29e-05 | 5 | 250 | 3 | CID000192297 | |
| Drug | Me-lex | 1.30e-05 | 14 | 250 | 4 | CID000004177 | |
| Drug | Oxolinic acid [14698-29-4]; Up 200; 15.4uM; MCF7; HT_HG-U133A | HLF IL20RA IL1RAPL2 GLRA2 GPLD1 DDX17 ETV7 FRMPD1 SLC10A1 PRKACG EPHB1 | 1.34e-05 | 199 | 250 | 11 | 2266_UP |
| Drug | pentylenetetrazol | 1.39e-05 | 130 | 250 | 9 | CID000005917 | |
| Drug | Perhexiline | 1.47e-05 | 29 | 250 | 5 | ctd:D010480 | |
| Drug | ebselen | 1.48e-05 | 131 | 250 | 9 | CID000003194 | |
| Drug | vigabatrin | 1.55e-05 | 49 | 250 | 6 | CID000005665 | |
| Drug | pheophytin | ABCC3 LDHAL6A CYP3A4 HPSE ABCB4 NT5C1A HPX ABCC2 NR0B2 LDHAL6B LDHA SLC10A1 PRKCE | 1.69e-05 | 284 | 250 | 13 | CID000000250 |
| Drug | senecionine | 1.70e-05 | 74 | 250 | 7 | ctd:C009237 | |
| Drug | davidigenin | 1.75e-05 | 30 | 250 | 5 | CID000442342 | |
| Drug | cyclothiazide | 1.83e-05 | 103 | 250 | 8 | CID000002910 | |
| Drug | Cholic Acid | 1.86e-05 | 75 | 250 | 7 | ctd:D019826 | |
| Drug | Chlorpyrifos | GABRB2 ABCC3 CYP3A7 MYO7A CYP3A4 SRPK2 DNAL1 TTF1 TENM2 SH3BP4 PARP1 WDR75 GLRA2 GLRB H1-10 CDC42BPA CASQ2 NPC2 HUWE1 GRM5 LDHA ZDHHC20 GNA14 LRRC8A PRKCE ATM | 2.24e-05 | 960 | 250 | 26 | ctd:D004390 |
| Drug | glutamate | GABRB1 GABRB2 GABRB3 GABRP LDHAL6A TRPC6 TRPM2 GABRQ NFASC RYR1 RYR3 PTPN12 TCERG1 GLRA2 GLRB NME2 GPLD1 LDHAL6B AASDH GRM5 LDHA PDIA4 PRKACG MTR PRKCE MAPK11 | 2.32e-05 | 962 | 250 | 26 | CID000000611 |
| Drug | NSC-114340 | 2.33e-05 | 16 | 250 | 4 | CID000004598 | |
| Drug | nimetazepam | 2.33e-05 | 16 | 250 | 4 | CID000004496 | |
| Drug | BL-443 | 2.55e-05 | 6 | 250 | 3 | CID000054436 | |
| Drug | dansyl-L-lysine | 2.55e-05 | 6 | 250 | 3 | CID000598797 | |
| Drug | I 65 | 2.55e-05 | 6 | 250 | 3 | CID000149068 | |
| Drug | D 701 | 2.55e-05 | 6 | 250 | 3 | CID003051460 | |
| Drug | 2,3-dihydroxy-1-naphthoic acid | 2.55e-05 | 6 | 250 | 3 | CID000028002 | |
| Drug | AC1L24G8 | 2.55e-05 | 6 | 250 | 3 | CID000066023 | |
| Drug | oxymethacil | 2.55e-05 | 6 | 250 | 3 | CID000096369 | |
| Drug | dibromosulphthalein | 2.55e-05 | 6 | 250 | 3 | CID000086995 | |
| Drug | SQ 32,926 | 2.55e-05 | 6 | 250 | 3 | CID000131363 | |
| Drug | Fura-2AM | 2.62e-05 | 79 | 250 | 7 | CID000105091 | |
| Drug | benzodiazepine | 2.82e-05 | 142 | 250 | 9 | CID000134664 | |
| Drug | 1,2,4-oxadiazole | 2.83e-05 | 33 | 250 | 5 | CID006451463 | |
| Drug | CGS 8216 | 2.83e-05 | 33 | 250 | 5 | CID000104916 | |
| Drug | AC1L2FYN | 2.83e-05 | 33 | 250 | 5 | CID000071333 | |
| Drug | zolpidem | 3.02e-05 | 17 | 250 | 4 | ctd:C049109 | |
| Drug | AC1L1KC5 | TRPC6 TRPM2 HPSE RYR1 RYR3 MAP3K5 PARP1 SACS ROCK2 GPLD1 CASQ2 GRM5 PDIA4 ATP2C1 PRKACG ROCK1 PRKCE MAPK11 | 3.30e-05 | 541 | 250 | 18 | CID000005428 |
| Drug | rifapentine | 3.38e-05 | 56 | 250 | 6 | CID006323497 | |
| Drug | flurazepam | 3.80e-05 | 35 | 250 | 5 | CID000003393 | |
| Drug | chlordiazepoxide | 3.82e-05 | 114 | 250 | 8 | CID000002712 | |
| Drug | 4-methoxy-1-naphthaldehyde | 3.85e-05 | 18 | 250 | 4 | CID000085217 | |
| Disease | melanoma | EPO ERCC5 MYO7A HPSE MAP3K5 PARP1 FAT4 IQCH UBR4 PPP6C ATM BZW1 | 1.37e-06 | 248 | 247 | 12 | C0025202 |
| Disease | Cardiomyopathies, Primary | 1.83e-06 | 69 | 247 | 7 | C0033141 | |
| Disease | Myocardial Diseases, Secondary | 1.83e-06 | 69 | 247 | 7 | C0036529 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 3.35e-06 | 49 | 247 | 6 | DOID:0060037 (implicated_via_orthology) | |
| Disease | X-21470 measurement | 4.49e-06 | 14 | 247 | 4 | EFO_0800817 | |
| Disease | Cardiomyopathies | 1.45e-05 | 130 | 247 | 8 | C0878544 | |
| Disease | epididymis-specific alpha-mannosidase measurement | 1.98e-05 | 7 | 247 | 3 | EFO_0801577 | |
| Disease | esterified cholesterol measurement, intermediate density lipoprotein measurement | 3.15e-05 | 8 | 247 | 3 | EFO_0008589, EFO_0008595 | |
| Disease | Immunologic Deficiency Syndromes | 3.74e-05 | 23 | 247 | 4 | C0021051 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 4.21e-05 | 195 | 247 | 9 | DOID:1574 (implicated_via_orthology) | |
| Disease | androstenediol (3beta,17beta) disulfate (1) measurement | 4.69e-05 | 9 | 247 | 3 | EFO_0800278 | |
| Disease | level of Sterol ester (27:1/18:2) in blood serum | 6.20e-05 | 26 | 247 | 4 | OBA_2045194 | |
| Disease | androstenediol (3beta,17beta) monosulfate (2) measurement | 9.10e-05 | 11 | 247 | 3 | EFO_0800295 | |
| Disease | cancer (implicated_via_orthology) | 9.52e-05 | 268 | 247 | 10 | DOID:162 (implicated_via_orthology) | |
| Disease | Malignant neoplasm of breast | GABRP ERCC6 CYP3A4 HPSE PARP1 IL1RAPL2 OTOGL MKI67 ACCS DNAH9 UBR4 FRMPD1 LDHAL6B PPA1 TECTA EPG5 KMT2D MRPS23 MTR FKBPL ATM SORL1 | 1.12e-04 | 1074 | 247 | 22 | C0006142 |
| Disease | 5alpha-androstan-3beta,17beta-diol monosulfate (2) measurement | 1.21e-04 | 12 | 247 | 3 | EFO_0800291 | |
| Disease | asthma exacerbation measurement | 1.34e-04 | 93 | 247 | 6 | EFO_0007614 | |
| Disease | hearing impairment | 1.79e-04 | 98 | 247 | 6 | C1384666 | |
| Disease | esterified cholesterol measurement, low density lipoprotein cholesterol measurement | 1.97e-04 | 14 | 247 | 3 | EFO_0004611, EFO_0008589 | |
| Disease | 5alpha-androstan-3alpha,17alpha-diol monosulfate measurement | 1.97e-04 | 14 | 247 | 3 | EFO_0800283 | |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 2.08e-04 | 3 | 247 | 2 | DOID:3529 (implicated_via_orthology) | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 2.08e-04 | 3 | 247 | 2 | DOID:8545 (implicated_via_orthology) | |
| Disease | sulfhydryl oxidase 1 measurement | 2.08e-04 | 3 | 247 | 2 | EFO_0802099 | |
| Disease | uric acid measurement | NOLC1 PDE1A HLF HNF4A TENM2 FAT4 CDC42BPA DNAJC16 HECTD4 BAZ1B MYOF SLC10A1 SLC17A1 ASXL2 SNX1 | 2.15e-04 | 610 | 247 | 15 | EFO_0004761 |
| Disease | X-21410 measurement | 2.99e-04 | 16 | 247 | 3 | EFO_0800813 | |
| Disease | rhinitis | 3.61e-04 | 17 | 247 | 3 | EFO_0008521 | |
| Disease | tacrolimus measurement | 4.14e-04 | 4 | 247 | 2 | EFO_0008458 | |
| Disease | estrone conjugate measurement | 4.14e-04 | 4 | 247 | 2 | EFO_0007971 | |
| Disease | Cerebrooculofacioskeletal Syndrome 1 | 4.14e-04 | 4 | 247 | 2 | C0220722 | |
| Disease | prolyl 4-hydroxylase subunit alpha-2 measurement | 4.14e-04 | 4 | 247 | 2 | EFO_0802918 | |
| Disease | Prescription Drug Abuse | 4.26e-04 | 115 | 247 | 6 | C4316881 | |
| Disease | Substance-Related Disorders | 4.26e-04 | 115 | 247 | 6 | C0236969 | |
| Disease | Organic Mental Disorders, Substance-Induced | 4.26e-04 | 115 | 247 | 6 | C0029231 | |
| Disease | Drug habituation | 4.26e-04 | 115 | 247 | 6 | C0013170 | |
| Disease | Drug abuse | 4.26e-04 | 115 | 247 | 6 | C0013146 | |
| Disease | Drug Use Disorders | 4.26e-04 | 115 | 247 | 6 | C0013222 | |
| Disease | Drug Dependence | 4.26e-04 | 115 | 247 | 6 | C1510472 | |
| Disease | Substance Dependence | 4.26e-04 | 115 | 247 | 6 | C0038580 | |
| Disease | Substance Use Disorders | 4.26e-04 | 115 | 247 | 6 | C0038586 | |
| Disease | syndrome (implicated_via_orthology) | 4.31e-04 | 18 | 247 | 3 | DOID:225 (implicated_via_orthology) | |
| Disease | very low density lipoprotein cholesterol measurement, esterified cholesterol measurement | 4.31e-04 | 18 | 247 | 3 | EFO_0008317, EFO_0008589 | |
| Disease | 5alpha-androstan-3alpha,17beta-diol monosulfate (1) measurement | 4.31e-04 | 18 | 247 | 3 | EFO_0800288 | |
| Disease | Substance abuse problem | 4.46e-04 | 116 | 247 | 6 | C0740858 | |
| Disease | cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 5.58e-04 | 121 | 247 | 6 | EFO_0008595, EFO_0020943 | |
| Disease | Colorectal Neoplasms | 5.82e-04 | 277 | 247 | 9 | C0009404 | |
| Disease | glaucoma (is_marker_for) | 5.95e-04 | 20 | 247 | 3 | DOID:1686 (is_marker_for) | |
| Disease | Primary Ciliary Dyskinesia | 6.44e-04 | 47 | 247 | 4 | C4551720 | |
| Disease | tauro-beta-muricholate measurement | 6.86e-04 | 5 | 247 | 2 | EFO_0800213 | |
| Disease | MENTAL RETARDATION, AUTOSOMAL DOMINANT 12 | 6.86e-04 | 5 | 247 | 2 | C3281201 | |
| Disease | glyco-beta-muricholate measurement | 6.86e-04 | 5 | 247 | 2 | EFO_0800569 | |
| Disease | disease of metabolism (implicated_via_orthology) | 6.89e-04 | 21 | 247 | 3 | DOID:0014667 (implicated_via_orthology) | |
| Disease | cholestasis (biomarker_via_orthology) | 7.55e-04 | 49 | 247 | 4 | DOID:13580 (biomarker_via_orthology) | |
| Disease | X-24947 measurement | 7.93e-04 | 22 | 247 | 3 | EFO_0800910 | |
| Disease | Nonsyndromic Hearing Loss and Deafness, Autosomal Recessive | 8.79e-04 | 51 | 247 | 4 | cv:CN043650 | |
| Disease | Colorectal Carcinoma | ZDHHC2 ABCC3 ERCC6 TCERG1L ABCB4 PARP1 SACS MKI67 ABCC2 NME2 APOB GUCY2C PRKCE SLC33A1 SORL1 | 9.18e-04 | 702 | 247 | 15 | C0009402 |
| Disease | total phospholipids in lipoprotein particles measurement | 1.02e-03 | 53 | 247 | 4 | EFO_0022315 | |
| Disease | larynx cancer (is_implicated_in) | 1.02e-03 | 6 | 247 | 2 | DOID:2596 (is_implicated_in) | |
| Disease | VACTERL association (implicated_via_orthology) | 1.02e-03 | 6 | 247 | 2 | DOID:14679 (implicated_via_orthology) | |
| Disease | dehydroisoandrosterone sulfate DHEA-S measurement | 1.02e-03 | 6 | 247 | 2 | EFO_0021119 | |
| Disease | interleukin-1 receptor-like 1 measurement | 1.02e-03 | 6 | 247 | 2 | EFO_0801713 | |
| Disease | androstenediol (3beta,17beta) monosulfate (1) measurement | 1.02e-03 | 6 | 247 | 2 | EFO_0800294 | |
| Disease | Idiopathic generalized epilepsy | 1.02e-03 | 6 | 247 | 2 | cv:C0270850 | |
| Disease | Cockayne syndrome (implicated_via_orthology) | 1.02e-03 | 6 | 247 | 2 | DOID:2962 (implicated_via_orthology) | |
| Disease | Pseudoaphakia | 1.03e-03 | 24 | 247 | 3 | C0524524 | |
| Disease | Lens Opacities | 1.03e-03 | 24 | 247 | 3 | C1510497 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 1.15e-03 | 139 | 247 | 6 | DOID:3908 (is_implicated_in) | |
| Disease | response to peginterferon alfa-2a | 1.16e-03 | 25 | 247 | 3 | EFO_0010103 | |
| Disease | epiandrosterone sulfate measurement | 1.16e-03 | 25 | 247 | 3 | EFO_0021120 | |
| Disease | stomach cancer (is_marker_for) | 1.28e-03 | 142 | 247 | 6 | DOID:10534 (is_marker_for) | |
| Disease | level of Sterol ester (27:1/16:0) in blood serum | 1.31e-03 | 26 | 247 | 3 | OBA_2045191 | |
| Disease | bilirubin measurement | MGAT4D EPO HNF4A ABCC2 FAT4 APOB USP40 PRKCE ASXL2 DNAH11 EPHB1 | 1.34e-03 | 442 | 247 | 11 | EFO_0004570 |
| Disease | Embryo Loss | 1.43e-03 | 7 | 247 | 2 | C0752351 | |
| Disease | Embryo Death | 1.43e-03 | 7 | 247 | 2 | C0752350 | |
| Disease | Epilepsy, Absence, Atypical | 1.43e-03 | 7 | 247 | 2 | C0751124 | |
| Disease | Juvenile Absence Epilepsy | 1.43e-03 | 7 | 247 | 2 | C4317339 | |
| Disease | Childhood Absence Epilepsy | 1.43e-03 | 7 | 247 | 2 | C4281785 | |
| Disease | X-24574 measurement | 1.43e-03 | 7 | 247 | 2 | EFO_0800897 | |
| Disease | bilirubin metabolic disorder (biomarker_via_orthology) | 1.43e-03 | 7 | 247 | 2 | DOID:2741 (biomarker_via_orthology) | |
| Disease | Blastocyst Disintegration | 1.43e-03 | 7 | 247 | 2 | C0012684 | |
| Disease | Akinetic Petit Mal | 1.43e-03 | 7 | 247 | 2 | C0001890 | |
| Disease | Absence Seizure Disorder | 1.43e-03 | 7 | 247 | 2 | C4553705 | |
| Disease | Embryo Resorption | 1.43e-03 | 7 | 247 | 2 | C0013937 | |
| Disease | perinatal necrotizing enterocolitis (is_marker_for) | 1.43e-03 | 7 | 247 | 2 | DOID:8677 (is_marker_for) | |
| Disease | Epilepsy, Minor | 1.43e-03 | 7 | 247 | 2 | C4552765 | |
| Disease | Absence Epilepsy | 1.43e-03 | 7 | 247 | 2 | C0014553 | |
| Disease | Embryo Disintegration | 1.43e-03 | 7 | 247 | 2 | C1136082 | |
| Disease | cholesterol to total lipids in medium LDL percentage | 1.46e-03 | 27 | 247 | 3 | EFO_0022238 | |
| Disease | low density lipoprotein cholesterol measurement, alcohol consumption measurement | 1.49e-03 | 99 | 247 | 5 | EFO_0004611, EFO_0007878 | |
| Disease | type 2 diabetes mellitus (biomarker_via_orthology) | 1.53e-03 | 147 | 247 | 6 | DOID:9352 (biomarker_via_orthology) | |
| Disease | low density lipoprotein cholesterol measurement, alcohol drinking | 1.70e-03 | 102 | 247 | 5 | EFO_0004329, EFO_0004611 | |
| Disease | cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement | 1.77e-03 | 103 | 247 | 5 | EFO_0008595, EFO_0020944 | |
| Disease | syndromic X-linked intellectual disability (implicated_via_orthology) | 1.89e-03 | 8 | 247 | 2 | DOID:0060309 (implicated_via_orthology) | |
| Disease | Cholestasis of pregnancy | 1.89e-03 | 8 | 247 | 2 | C0268318 | |
| Disease | lysosomal Pro-X carboxypeptidase measurement | 1.89e-03 | 8 | 247 | 2 | EFO_0801777 | |
| Disease | lipoprotein measurement | 1.93e-03 | 105 | 247 | 5 | EFO_0004732 | |
| Disease | low density lipoprotein cholesterol measurement, physical activity | 2.30e-03 | 66 | 247 | 4 | EFO_0003940, EFO_0004611 | |
| Disease | opportunistic bacterial infectious disease (implicated_via_orthology) | 2.42e-03 | 9 | 247 | 2 | DOID:0050340 (implicated_via_orthology) | |
| Disease | cholestasis (implicated_via_orthology) | 2.42e-03 | 9 | 247 | 2 | DOID:13580 (implicated_via_orthology) | |
| Disease | interleukin 18 receptor accessory protein measurement | 2.42e-03 | 9 | 247 | 2 | EFO_0008179 | |
| Disease | glycosyl-N-palmitoyl-sphingosine (d18:1/16:0) measurement | 2.42e-03 | 9 | 247 | 2 | EFO_0800476 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YVPFWQKKTFPEIID | 811 | Q15361 | |
| LKLLWAPLVDAVYVK | 121 | O00400 | |
| WYVPLSLKNVDKVLE | 161 | O00154 | |
| DVWKFAPNLITVKKY | 306 | Q9Y5B0 | |
| VYPSSVEEEAKLFLW | 2406 | Q9HCE0 | |
| VKFIKLAFTYEEWSL | 486 | Q96N23 | |
| AKKVFSPVWDYFVAS | 1036 | Q96N23 | |
| YSVEFIRPDFDKKWT | 176 | Q63HQ2 | |
| TEVIKYTLDPVWKPF | 196 | Q96FN4 | |
| WIRSKYEEKLFLAPL | 611 | Q5VTM2 | |
| VKVYFTWLAPSDEDK | 471 | Q6Y288 | |
| FYKAEVLSEEPILKW | 366 | Q7L1Q6 | |
| VLSEEPILKWYKDAH | 371 | Q7L1Q6 | |
| VWEEAKIFYDNLAPK | 26 | Q9BXI3 | |
| FIWVDLRKYLPKGTF | 411 | Q96QU6 | |
| DPIYFFALVDTKAVW | 341 | Q96NH3 | |
| ALVQEKLAEPWKVYL | 996 | Q86V15 | |
| LKEEFPAWYEKLVLE | 76 | Q9UIG0 | |
| LVLKDTSYGKPVDIW | 171 | Q8IVW4 | |
| IKTFVDVLWYKLTPA | 2081 | Q7Z2Y8 | |
| PLDFEKIQKYVVWIE | 2626 | Q6V0I7 | |
| PYATLKKWISLTNFI | 126 | Q9Y312 | |
| KSTFVKLLTKTYPEW | 51 | Q16854 | |
| KANPSLDTWKIYVEF | 896 | Q96DT5 | |
| NDIFLWYTAAKKPEL | 346 | Q9Y2F9 | |
| WYTAAKKPELQFVSK | 351 | Q9Y2F9 | |
| AVDFYSGKVKWEQIL | 796 | Q4L235 | |
| LSDYFIVQWPALKEK | 191 | Q96F25 | |
| WIYFQAPVKIAVIFK | 1316 | Q7Z478 | |
| KEKFIPPELSIWDYF | 2421 | Q9Y485 | |
| SEDEPLWKKYISQFK | 66 | P98194 | |
| KLFSYAITEWLNDIK | 1866 | Q96BY7 | |
| RTWAEAAKTVLEKYP | 11 | Q76L83 | |
| FSKDKDIIPFIDKYW | 191 | Q9UBL3 | |
| VILPKWAKSAEDFIY | 2186 | Q6ZS30 | |
| FDLLNIVPWLKKYGT | 61 | Q13356 | |
| LDIYSFWLKSAKVPE | 51 | Q14978 | |
| KALAEDVKAWRPALY | 81 | O00391 | |
| IAPTVWKLADRSKIY | 286 | O00391 | |
| DWEFKISVLYDIAKG | 586 | P25092 | |
| KTPLRALKSLWDYDF | 256 | Q86VS3 | |
| YPTDRDSIWKCLKFL | 496 | Q96HW7 | |
| KEWVTPKEFREISYL | 331 | P09874 | |
| NGIKVLKLYAWEPSF | 496 | O15438 | |
| LKLYAWEPSFLKQVE | 501 | O15438 | |
| TFPKEWKTSDLYQLF | 451 | O95453 | |
| SEWKIPLFLAFLVIY | 21 | P0DN80 | |
| DILTYVAWKISGFPK | 141 | P00338 | |
| KFTDIKEIPLWIYSL | 501 | Q8IWT6 | |
| KEIPLWIYSLKTLEE | 506 | Q8IWT6 | |
| SLWFKPEELVDYKSC | 131 | P22392 | |
| AWQLHKTYDEKPVDF | 966 | P0DP91 | |
| KSEYPSIKLVVEWQL | 116 | P61916 | |
| KIPDLTYASKIVQWL | 996 | Q6IE37 | |
| IATKKSAFWSEAPYL | 121 | P54762 | |
| EAKWLPYKTRNITVF | 476 | Q6W4X9 | |
| RVFNPVIKWYIKDSD | 281 | O95256 | |
| WGEKIFYLIKPTDEN | 296 | Q6ZMT4 | |
| EWKELTYQEVLSFKP | 336 | Q15759 | |
| TIKLQSPDVKWFDDY | 326 | P41594 | |
| KWTEPYCVIAAVKIF | 61 | Q17RY6 | |
| FPYILADDKWHKLSL | 141 | Q99435 | |
| FLPWEKKKYFQDLLD | 891 | Q3T906 | |
| EELKLKEKTYSLWPF | 446 | Q9Y217 | |
| KEKTYSLWPFLLEDQ | 451 | Q9Y217 | |
| DAPWKIFLRKEVFYP | 2686 | Q9UKN7 | |
| FDLFNPDYVPKVDKW | 596 | Q9UN88 | |
| PDYVPKVDKWSRFLF | 601 | Q9UN88 | |
| SLAKIYTEAKKVPWF | 66 | Q92522 | |
| KEPLYSNWAKHFVVV | 1711 | O60333 | |
| YPVWLSKEAVSILKA | 626 | Q02156 | |
| WVLLTPKAKEQYAVV | 431 | O75882 | |
| IVYPTEKVNCLDKFW | 11 | Q14847 | |
| KYWTEPEKFLPERFS | 406 | P08684 | |
| LVLVEWAKYIPAFCE | 196 | P41235 | |
| ILTYVAWKLSAFPKN | 191 | Q9BYZ2 | |
| EQSKTFYKPDWFDIV | 496 | Q8NCN5 | |
| YPAAVIVTLKDVDKW | 146 | P54750 | |
| LLVKRFIPKYSTFWA | 196 | A6NFY4 | |
| SPYWKEALNILKLVV | 2236 | O94915 | |
| YCKIIDSKETWIPFN | 46 | O94830 | |
| DSFKKPYLIKITSDW | 156 | Q9Y2G8 | |
| QLSDLYFVEPKWLCK | 1591 | Q5S007 | |
| DKDLYILWKGPSFDV | 431 | Q9NY33 | |
| EFAAKFIVPYDVWAS | 61 | Q9UJQ1 | |
| KAASAPYFEVLEKWI | 381 | Q9BSJ2 | |
| FSFDYIVKWPLSLII | 616 | Q9BSJ2 | |
| IKWAKYSLDVLLFGE | 831 | Q96RT8 | |
| LWVPDTYFLNDKKSF | 116 | P18505 | |
| WVPDTYFLNDKKSFV | 116 | P47870 | |
| LWVPDTYFLNDKKSF | 116 | P28472 | |
| PKVSYVKALDVWLIA | 321 | P48167 | |
| LSGIKILKYFAWEPS | 506 | Q92887 | |
| PAVIFKYIEGWTALE | 251 | P57789 | |
| PFWKLYESVKKELDV | 236 | P46013 | |
| KVFIPDDLKDDKYWA | 216 | Q16534 | |
| KDSSLYKAPWARVLV | 2606 | Q9Y4D8 | |
| SSYKEKVLPWFEQLL | 851 | O00410 | |
| FWSLELSPKEYACLK | 156 | Q15466 | |
| SWLFKAATLPNEYKE | 996 | Q2PPJ7 | |
| KWITPVLLLIDFYEK | 1581 | Q7Z6Z7 | |
| IKDKESFYPLIDVNW | 381 | A2RRP1 | |
| KEADAYTPLWFEKRL | 871 | Q969R2 | |
| LPDYWLSLLFKKLVG | 401 | Q9Y251 | |
| AKCSEPLVDLIYFWK | 276 | Q9NZU5 | |
| EFKAKIIFWYVLPVS | 246 | Q9UHF4 | |
| FYKEKPIDWLLNDIF | 311 | A6NG13 | |
| LKLNKTEWPYFVVGT | 701 | P21439 | |
| KIWSKEGFYAVVIFL | 221 | Q15256 | |
| TWDEIFPLKKLYALD | 121 | O94913 | |
| IAIFWCYEKFKTPKD | 301 | Q14973 | |
| ILKWVKLIDNFEGEY | 276 | P48147 | |
| WAPKAFIISFKLETD | 221 | Q9HAB8 | |
| NPLYTEWILEAIKKV | 6 | Q92794 | |
| LKLTVSWLKDDEPLY | 551 | O94856 | |
| KEKLVYAIFLKWPTS | 391 | Q9BTY2 | |
| EKEWSTILFNVLPYK | 1166 | Q9P2D7 | |
| LKTLLEADPYSKWAI | 1046 | Q13315 | |
| ILPVYDKSLWDFLKL | 3676 | P04114 | |
| LWYCPDGSFVKKIVI | 96 | Q9UIM3 | |
| EATLLWRDIAKPYKT | 356 | Q01638 | |
| TWVKYNPLESLIKDV | 116 | Q86XP6 | |
| WVDGSPIDSKIFFIK | 186 | Q9NZS2 | |
| TSWIAIYEKKVEAPF | 301 | P22612 | |
| KIALQFPYRFWDSKV | 661 | Q8NB78 | |
| AEFYDPLKEKWIPIA | 386 | Q8NBE8 | |
| KWLLEDFSCKIVPYI | 326 | O15354 | |
| EGKAVDWFTFYKLPK | 36 | Q8WZ79 | |
| TAYKLPGILRWFEVK | 1466 | Q14185 | |
| PYIKWEDKDAKIFRV | 241 | Q9Y603 | |
| PVSFLQLKFWKIYLE | 201 | Q5R3K3 | |
| ISLKYIEKDWGIENF | 326 | Q5SYB0 | |
| ISLKYIEKEWGLETF | 351 | Q14CM0 | |
| ELKDKETNYFFVEPW | 416 | Q96PZ2 | |
| VKEKYPDLANFWHEL | 816 | Q8IVF7 | |
| AKFPIKWTAPEAALY | 426 | P06241 | |
| VEVPSVILKEWSAYK | 686 | Q9NX05 | |
| AVDALYIKAAWLKAT | 41 | Q9NPH9 | |
| YIKAAWLKATIPEDR | 46 | Q9NPH9 | |
| VWLDEYKEQFFLRKP | 386 | Q7Z4T8 | |
| GLIFDRKKVYITWPD | 66 | O75936 | |
| NSVWEPAKAKYVFRD | 301 | P09871 | |
| YSVGPENFEIVKKWL | 46 | Q96P44 | |
| ITVPDTKVNFYAWKR | 66 | P01588 | |
| QFSVKEFYLKIIPWR | 361 | O15033 | |
| LYWKELAVLAQKIGF | 211 | Q9HBK9 | |
| DNWTYSKEFKIPFEI | 76 | O00462 | |
| PVLWKFLEKYPSAEV | 476 | O95243 | |
| ASLPKVSYVKAIDIW | 306 | P23416 | |
| KRLKPGYLEATVDWF | 176 | Q15181 | |
| LEWYTAKDFIVGKSL | 321 | Q5JVL4 | |
| FPLLVAYWEKTFKID | 311 | O14958 | |
| AYWEKTFKIDLFRPQ | 316 | O14958 | |
| KWDLSELPKFEKNFY | 121 | Q92841 | |
| PTPKVELEFWKSRYE | 246 | Q9NYC9 | |
| KYWTEPEKFLPERFS | 406 | P24462 | |
| EELWISYNFIEKLKG | 96 | Q4LDG9 | |
| EYPDLFEWFCVKTLK | 111 | Q6UXH1 | |
| GYFLFSWKKAVVVDI | 171 | O15431 | |
| IKQEVEDYLPSFCKW | 206 | P51530 | |
| YIPWDKVKPEELESF | 601 | O95104 | |
| LSVDVIYKLWPEASK | 526 | Q9NZJ4 | |
| TFSEKDKEIYRWPIK | 2796 | P21817 | |
| YIFVKSWSGDPFLKD | 106 | Q68D06 | |
| LYPDKKFEIVKLASW | 1586 | P25940 | |
| EKFWKVSRPLELCYA | 386 | Q06587 | |
| WVPDTYIVESKKSFL | 116 | O00591 | |
| WLFRIPLKEYSFEKV | 386 | Q7L1W4 | |
| FTDVAEIPAWVYLLK | 546 | Q7L1W4 | |
| YFPEKDITILWDRKT | 1046 | Q3ZCN5 | |
| TQDPFWKKIVFVIFL | 16 | Q8NGL9 | |
| SAYWKALKVFKLPVE | 321 | Q6J4K2 | |
| QASEKLFKLKTPAWY | 496 | Q99683 | |
| ESKALFKTIITYPWF | 246 | O95837 | |
| NSVFLIKGDKVWVYP | 106 | P02790 | |
| KFVPYRDSVLTWLLK | 301 | Q9NQT8 | |
| RAGVLKEKPLWFDVY | 21 | Q9Y3D9 | |
| PYSFFTKLTADELWK | 86 | P82675 | |
| FSKEIVCVPSYLELW | 341 | P52788 | |
| PLSQLLYWVDAGFKK | 841 | Q92673 | |
| PLVLYDCKFENVKWI | 321 | Q9BZE2 | |
| EFDKWAPSVVKISYK | 791 | P51531 | |
| LYPSTVWDFINKKVT | 461 | Q9P0V3 | |
| IFPVEDLWTKAAIDY | 601 | B5MCY1 | |
| WRLKDEDLLPSKYFE | 106 | Q9UIC8 | |
| VSYAIDTLKAKVPIW | 151 | O96007 | |
| VVDPFSKKDWYDVKA | 21 | P61247 | |
| WYKNKGDLEEPIIFS | 76 | Q9NP60 | |
| GLVAKPFEKVTYRWT | 506 | Q9BQS7 | |
| AVCLLWFVLFYDDPK | 211 | Q14916 | |
| YLKPVVDDSKGSFLW | 936 | P28715 | |
| LQKLVDYIDWKPFFD | 966 | Q99707 | |
| EELKWTAFTFLKIPQ | 301 | O75448 | |
| FPKELLKALYWSIRS | 721 | Q8NDX1 | |
| YTWNLLKAGKIPEEF | 246 | Q05209 | |
| EFDKWAPSVVKVSYK | 821 | P51532 | |
| LKFEQIYLSKPTHWE | 86 | P30876 | |
| WKTNPSVFFVKYEEA | 161 | Q9BZQ2 | |
| ATIFWLLKYRPEFLK | 156 | Q9UHJ6 | |
| LEYLDKWFVLDDILP | 516 | Q6P3W7 | |
| WPAVKSFYDRIKLLA | 896 | Q9NT68 | |
| FAWALKYLPKTLAEN | 441 | Q96SF2 | |
| VDLSWKAELLPTIKY | 411 | Q75T13 | |
| VADKDTVLLEFYAPW | 76 | P13667 | |
| ALLYGFLPDFDWKKI | 216 | Q8TE99 | |
| KNILEYLEWAKPFTS | 51 | Q5VT25 | |
| LPWEIVYIFKQVLKD | 111 | P0DJH9 | |
| SLFSTYKEKILPWFE | 856 | O60518 | |
| KSGFIEWNEIKYILS | 71 | A0A1B0GWK0 | |
| WIRSKYEEKLFLAPL | 566 | A6NIR3 | |
| TVDDFLLEKWRKYFP | 1351 | Q9UPV0 | |
| KFPWKLTDAIDEYDV | 656 | Q96JI7 | |
| TDFGLKVVYDWKTFL | 1211 | O75443 | |
| KVVYDWKTFLSITVP | 1216 | O75443 | |
| TWEKELHKIVFDPRY | 471 | Q5VWI1 | |
| KWLFETQPLDSIKYF | 881 | A4UGR9 | |
| KITTFDRPAYLWLKQ | 106 | Q9NYW4 | |
| GTKFDTLWQLVEYLK | 226 | P43403 | |
| FGDEKKYWLLPIFSS | 271 | Q5W0Z9 | |
| EYKVELDLWLKTLSP | 286 | P0CB48 | |
| DIVLSWFPFYFELKI | 56 | Q9BRK0 | |
| FELKIAFVIWLLSPY | 66 | Q9BRK0 | |
| KIVQLLKEWTEAFPY | 116 | Q8N9B8 | |
| QLAKYWEAFLPEAKA | 506 | Q13596 | |
| FYKIEIPEVLLWAKE | 856 | Q13905 | |
| PKYRVKEWLLSDVIS | 76 | O43511 | |
| WEKELHKIVFDPRYL | 681 | O14776 | |
| GVWKKLIPTLIDDYE | 401 | Q96MW7 | |
| ETFTYLLALKAKWPD | 91 | O00743 | |
| LVTASKDGYFKVWIL | 461 | Q8IWA0 | |
| PFKTLTEKEKEIYRW | 2656 | Q15413 | |
| LETPEIYWKLDSKAV | 801 | Q15431 | |
| SWIPENIKKKECVYF | 61 | O94759 | |
| AIDFPATYTKDKKWN | 141 | Q7Z6L1 | |
| LILDIKRKAPYFWSD | 486 | Q6U841 | |
| LKPWSLFDVLVEKYG | 636 | P78362 | |
| WARAVVPKIFYVTEK | 71 | Q9UKF7 | |
| LPWEKDTEKLVAFLF | 106 | P80108 | |
| ILQYIWSFELPEIKK | 556 | Q9H5I5 | |
| WGYLKEDFLVKPEVL | 331 | Q7Z410 | |
| VPEKWAKFYTAEVVL | 186 | O75116 | |
| FEKALVWYESTLKLQ | 1101 | Q96AE7 | |
| PEKWARFYTAEVVLA | 171 | Q13464 | |
| YIWDIKDTRKPTVAL | 131 | Q6PJI9 | |
| YEKWEIDPSELAFIK | 261 | P42681 | |
| LLFVTEYLTKWPKFF | 111 | O43592 | |
| EYLTKWPKFFFDILS | 116 | O43592 | |
| FSEPVYAAFWLSKKE | 526 | O95361 | |
| ICLKEKYSPWDALFT | 176 | Q2M3R5 | |
| QKAWKIYPPEFAVEI | 56 | Q5T6R2 | |
| VFGDEKKYWLLPIFS | 271 | Q9UIJ5 | |
| KEIWTQGPKEYLFEL | 511 | Q9Y210 | |
| AYNPALIWKEIKSFL | 1296 | O15050 | |
| KRIVFYGDETWVKLF | 156 | Q5H8A4 | |
| EIEFYAKVNSKPVWL | 96 | E9PB15 | |
| SLDLPVAEVYKKVWC | 4416 | Q5T4S7 | |
| KIEIAKYFPEKFEWL | 1116 | Q9NVE5 | |
| FKIWDSFLYEGPKVI | 846 | Q9UPU7 | |
| FTFGLDWVPKKLDVS | 576 | P45974 | |
| VVQSLKEYEGKWLLF | 736 | O94782 | |
| ADFWLTEKDLIPKLF | 76 | Q9NRX2 | |
| WLLELSKKNIFPYHE | 1296 | P35573 | |
| WLKQFDAVLPGYTLK | 4856 | O14686 | |
| PFSKFDDLLKYLWAA | 196 | Q6P5S2 | |
| DILTYVAWKLSGFPK | 141 | Q6ZMR3 | |
| ELWFAYEGLKKATRV | 1136 | Q9NQX4 | |
| LFVWIVDKINAAIYK | 406 | Q13402 | |
| FPSVCEKIKLTIYDW | 431 | Q9NZM1 | |
| FLAKKPWTRYVDIAL | 76 | Q9UHF3 |